<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq (Inicet, Psm-2) - QuizMaster Pro</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}


    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Late Night PYQ INICET
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 11152,
    "choices": [
      {
        "id": 44574,
        "text": "<p><span style=\"font-size:12.0pt;\">A child &lt; 2 years</span></p>"
      },
      {
        "id": 44575,
        "text": "<p><span style=\"font-size:12.0pt;\">A patient with sickle cell disease</span></p>"
      },
      {
        "id": 44576,
        "text": "<p><span style=\"font-size:12.0pt;\">A patient with cystic fibrosis</span></p>"
      },
      {
        "id": 44577,
        "text": "<p><span style=\"font-size:12.0pt;\">A patient with recurrent otitis media</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A new vaccine has been developed to target the 23 serotypes of <i>Streptococcus pneumoniae</i>. This polysaccharide vaccine promises to reduce the morbidity and mortality associated with pneumococcal infections, particularly in certain high-risk groups. Which of the following patient groups would most likely derive the most benefit from this vaccine? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q2616853",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305865,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) A patient with sickle cell disease&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The polysaccharide vaccine targeting Streptococcus pneumoniae (PPSV-23) provides the greatest advantages to individuals with sickle cell disease.</span></li><li><span style=\"font-size:12.0pt;\">Streptococcus pneumoniae is a bacteria enveloped in a protective layer that the spleen recognizes and eliminates.</span></li><li><span style=\"font-size:12.0pt;\">However, in the case of sickle cell disease, the distorted shape of red blood cells obstructs the spleen's blood vessels, leading to damage.</span></li><li><span style=\"font-size:12.0pt;\">This compromised spleen function, known as hyposplenism, raises the susceptibility to pneumococcal infections.</span></li><li><span style=\"font-size:12.0pt;\">Consequently, sickle cell patients receive the pneumococcal vaccine (PPSV-23) as a preventive measure, aimed at diminishing this vulnerability.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. A child &lt; 2 years:&nbsp;</strong>Polysaccharide vaccines are not effective in children under 2 years old due to their immature immune systems. Conjugate vaccines are preferred for this age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. A patient with cystic fibrosis:&nbsp;</strong>While at risk for lung infections, cystic fibrosis patients benefit more from vaccines targeting typical respiratory pathogens, and their spleen function is usually normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. A patient with recurrent otitis media:&nbsp;</strong>This condition is typically managed with other interventions, and the need for a polysaccharide vaccine is less critical.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The PPSV-23 vaccine is most beneficial for patients with sickle cell disease due to their increased susceptibility to pneumococcal infections caused by compromised spleen function.</span></li></ul>",
    "correct_choice_id": 44575,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11145,
    "choices": [
      {
        "id": 44546,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Pertussis</span></p>"
      },
      {
        "id": 44547,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Diphtheria</span></p>"
      },
      {
        "id": 44548,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Localized varicella zoster</span></p>"
      },
      {
        "id": 44549,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mycoplasma pneumonia</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">You're rotating in the infection control unit of a tertiary care hospital in Chennai. As part of your duties, you have been assigned to educate the staff about the importance of precautionary measures and isolation techniques for various conditions. While discussing droplet precautions, one of the staff inquired about the diseases for which such precautions are necessary. Which of the following conditions does NOT typically require precautionary measures and isolation due to droplet infection? </span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2018)</span></p>",
    "unique_key": "Q7361029",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305858,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) Localized varicella zoster</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Droplet precautions and isolation are unnecessary for localized varicella-zoster, as this virus is exclusively transmitted through direct contact.</span></li><li><span style=\"color:black;font-size:12.0pt;\">When varicella-zoster remains confined to a patient with a fully functioning immune system and can be effectively contained or covered, there is no need for droplet precautions.</span></li><li><span style=\"color:black;font-size:12.0pt;\">However, if varicella becomes disseminated in any patient, it necessitates both airborne and contact precautions.</span></li><li><span style=\"color:black;font-size:12.0pt;\">On the other hand, diseases like diphtheria, pertussis, and mycoplasma are transmitted via droplets and, therefore, demand droplet precautions and isolation measures.</span></li><li><span style=\"color:black;font-size:12.0pt;\">These precautions include the use of masks, gowns, gloves, and protective eye gear when delivering direct patient care.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pertussis:</strong> Requires droplet precautions due to transmission via respiratory droplets.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Diphtheria:</strong> Requires droplet precautions as it is spread through respiratory droplets.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mycoplasma pneumonia:</strong> Requires droplet precautions due to transmission via respiratory droplets.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Localized varicella zoster does not require droplet precautions as it is transmitted through direct contact, while conditions like pertussis, diphtheria, and mycoplasma pneumonia require droplet precautions due to their transmission via respiratory droplets.</span></li></ul>",
    "correct_choice_id": 44548,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 57819,
    "choices": [
      {
        "id": 230637,
        "text": "<p><span style=\"font-size:12.0pt;\">Less than 50%</span></p>"
      },
      {
        "id": 230638,
        "text": "<p><span style=\"font-size:12.0pt;\">70%</span></p>"
      },
      {
        "id": 230639,
        "text": "<p><span style=\"font-size:12.0pt;\">95%</span></p>"
      },
      {
        "id": 230640,
        "text": "<p><span style=\"font-size:12.0pt;\">72%</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A pharmaceutical company has developed a novel diagnostic test for a rare metabolic disorder. In clinical trials, the test demonstrated a sensitivity of 0.90 and a specificity of 0.80. In a population where the prevalence of the disease is 30%, the test was applied to every participant. What is the probability that a person who tests negative truly does not have the disease? (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q9362423",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305841,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 95%</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It\u2019s the Negative Predictive Value (NPV), which tells us the probability that a person with a negative test result truly doesn't have the disease.</span></li></ul><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NPV = TN / (TN + FN)</span></p><ul><li><span style=\"font-size:12.0pt;\">Use a hypothetical cohort of 1000 people for easy calculation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Disease prevalence = 30% = 300 people with the disease and 700 without the disease out of 1000.</span></li><li><span style=\"font-size:12.0pt;\">Sensitivity = 0.90, so TP = 0.90 * 300 = 270 and FN = 300 - 270 = 30.</span></li><li><span style=\"font-size:12.0pt;\">Specificity = 0.80, so TN = 0.80 * 700 = 560 and FP = 700 - 560 = 140.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Using the above formula:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NPV = 560 / (560 + 30) = 560 / 590 = 0.9491 or approximately 95%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The Negative Predictive Value (NPV) represents the probability that a person with a negative test result truly does not have the disease</span></li></ul>",
    "correct_choice_id": 230639,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11124,
    "choices": [
      {
        "id": 44462,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence increases and prevalence reduces</span></p>"
      },
      {
        "id": 44463,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence reduces and prevalence remains the same</span></p>"
      },
      {
        "id": 44464,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence remains the same and prevalence increases</span></p>"
      },
      {
        "id": 44465,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence reduces and prevalence increases</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A new combined treatment regimen of chemotherapy and immunotherapy has significantly increased survival in patients with metastatic melanoma. If the number of new cases remains consistent, but patients live longer, which epidemiological impact would be observed? (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q4596918",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305834,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Incidence remains the same and prevalence increases</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Due to the new drug combination, patient survival rates have risen, resulting in a situation where the incidence remains unchanged while prevalence sees an increase.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>PREVALENCE</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Total current (Old + New) cases in a given population over.</span></li><li><span style=\"font-size:12.0pt;\">Prevalence = Incidence \u00d7 Mean duration of disease [P = I \u00d7 d]</span></li><li><span style=\"font-size:12.0pt;\">Prevalence describes the balance between incidence, mortality and recovery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>INCIDENCE</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Number of new cases occurring in a defined population over a specified period of time.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Since New cases will keep on occurring at the same rate, Incidence will remain same. Duration will increase (as survival increases). So, overall Prevalence will increase.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">When patient survival increases due to a new treatment, the incidence of the disease remains the same, but the prevalence increases due to longer survival duration.</span></li></ul>",
    "correct_choice_id": 44464,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11132,
    "choices": [
      {
        "id": 44494,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Japanese encephalitis</span></span></span></span></p>"
      },
      {
        "id": 44495,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Zika virus</span></span></span></span></p>"
      },
      {
        "id": 44496,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Rabies</span></span></span></span></p>"
      },
      {
        "id": 44497,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Nipah virus</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">You&#39;re a physician attending a conference on emerging infectious diseases. As the discussion shifts towards the recent outbreaks in South India, the speaker displays an image showcasing the life cycle of a specific virus. A fellow physician sitting beside you, being relatively unfamiliar with the recent disease trends in South India, asks for your insights about the virus in question. Given the depicted life cycle and the associated clinical syndromes, which of the following viruses would be the most likely culprit? </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(AIIMS NOV 2018)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip35.jpg\" style=\"height:364px; width:200px\" /></p>",
    "unique_key": "Q8119550",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305845,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. D) Nipah virus</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">NIPAH Virus</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Genus: Henapi virus</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Transmission in India:</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Occurrence: West Bengal, Kerela (<span style=\"background-color:white\">Kozhikode district</span>)</span></span></strong></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Route: Consumption of fruits contaminated with bats (Pteropus: &lsquo;Flying foxes&rsquo;) secretions (<strong>person - person in India</strong>)&nbsp;</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Direct contact with infected bats, infected pigs, infected people</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Clinical presentation: Encephalitis</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IP is 4-14 days</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Case fatality rate: 50%</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Vaccine: NONE for humans</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Treatment: Intensive supportive care</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">High-risk contacts and healthcare workers, who are under quarantine and monitoring for 21 days</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">WHO included Nipah virus under list of <strong>Emerging Diseases likely to cause Major Epidemics&nbsp;</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Comes under <strong>Category C of Bioterrorism agent&nbsp;</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture1433_VvVb14m.jpg\" style=\"height:423px; width:500px\" /></strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Japanese encephalitis:</span></strong><span style=\"font-size:12.0pt\"> Transmitted by mosquitoes and does not involve fruit bats or the depicted transmission cycle.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Zika virus:</span></strong><span style=\"font-size:12.0pt\"> Transmitted by mosquitoes, primarily the Aedes species, and does not match the transmission cycle shown in the image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">ZIKA VIRUS LIFE CYCLE</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/screenshot-2023-10-20-192633_MN2X6SF.jpg\" style=\"height:377px; width:700px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Rabies:</span></strong><span style=\"font-size:12.0pt\"> Transmitted through the bites of infected animals (typically dogs or other mammals) and does not involve fruit bats or the depicted transmission cycle.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nipah virus, transmitted through fruit bats and causing encephalitis, fits the transmission cycle shown in the image and is a significant emerging infectious disease in regions such as Malaysia and Bangladesh.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 44497,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 11089,
    "choices": [
      {
        "id": 44322,
        "text": "<p><span style=\"font-size:12.0pt;\">Weight 55 kgs</span></p>"
      },
      {
        "id": 44323,
        "text": "<p><span style=\"font-size:12.0pt;\">Height 1.73 m</span></p>"
      },
      {
        "id": 44324,
        "text": "<p><span style=\"font-size:12.0pt;\">Works 10 hours/day</span></p>"
      },
      {
        "id": 44325,
        "text": "<p><span style=\"font-size:12.0pt;\">Age of 18-25 years</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Dr. Verma is examining the criteria used to establish the Recommended Daily Allowance (RDA) for nutrients and focuses on the typical characteristics of a \"reference woman\". Which of the following correctly describes this reference woman used for RDA calculations? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q8693521",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305828,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Weight 55 kgs</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Weight of 55 kgs:</strong> This is used as a standard measurement in RDA calculations to reflect an average baseline for determining nutrient needs in adult women.</span></li><li><span style=\"font-size:12.0pt;\">It represents a balance that is thought to be typical or ideal for maintaining health without excessive caloric intake.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The reference woman used in the calculation of recommended daily allowance (RDA)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Aged between 19-39 years</span></li><li><span style=\"font-size:12.0pt;\">Non pregnant, non-lactating</span></li><li><span style=\"font-size:12.0pt;\">Weight=55kgs</span></li><li><span style=\"font-size:12.0pt;\">Height = 1.61 m</span></li><li><span style=\"font-size:12.0pt;\">BMI=21.2</span></li><li><span style=\"font-size:12.0pt;\">Free from disease and physically fit for active work</span></li><li><span style=\"font-size:12.0pt;\">Engaged in moderate activity for 8 hours on each working day</span></li><li><span style=\"font-size:12.0pt;\">Spends 8 hours in bed, 4-6 hours in sitting and moving, 2hours in walking and in active recreation or household activities.</span></li></ul>",
    "correct_choice_id": 44322,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 57597,
    "choices": [
      {
        "id": 229757,
        "text": "<p><span style=\"font-size:12.0pt;\">Start breastfeeding as soon as possible</span></p>"
      },
      {
        "id": 229758,
        "text": "<p><span style=\"font-size:12.0pt;\">Clear eyes with a sterile swab</span></p>"
      },
      {
        "id": 229759,
        "text": "<p><span style=\"font-size:12.0pt;\">Bath to newborn with warm water</span></p>"
      },
      {
        "id": 229760,
        "text": "<p><span style=\"font-size:12.0pt;\">Cover baby\u2019s head and body</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A mother delivers in a rural area under the guidance of a skilled birth attendant. Incorrect regarding the care provided by the skilled birth attendant is: (NEET PG 2024)</span></p>",
    "unique_key": "Q9462199",
    "question_audio": null,
    "question_video": null,
    "map_id": 34306015,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Bath to newborn with warm water</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bathing a newborn immediately after birth is not recommended as it can cause rapid heat loss and hypothermia in the infant. Instead, after delivery, the newborn should be wiped clean with a sterile cloth and wrapped warmly without giving a bath. The bath can be delayed until at least 24 hours after birth or later when the baby\u2019s body temperature has stabilized, especially in settings without advanced care facilities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Start breastfeeding as soon as possible</strong>: It is recommended to initiate breastfeeding immediately after birth, ideally within the first hour for vaginal deliveries and within 4 hours for cesarean sections. Early breastfeeding provides the newborn with essential nutrients and antibodies and helps stimulate milk production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Clear eyes with a sterile swab</strong>: Clearing the eyes of a newborn with a sterile swab is correct. If needed, antiseptic solutions like <strong>1% silver nitrate or 1% tetracycline ointment</strong> can be used to prevent ophthalmia neonatorum, an eye infection that can occur in newborns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cover baby\u2019s head and body</strong>: Covering the baby\u2019s head and body immediately after birth is essential to prevent heat loss. Newborns lose up to 75% of their body heat through the head, making it crucial to keep the baby warm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Newborns should not be bathed immediately after birth to prevent hypothermia; instead, they should be wiped clean and kept warm by wrapping them appropriately.</span></p>",
    "correct_choice_id": 229759,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 57599,
    "choices": [
      {
        "id": 229765,
        "text": "<p><span style=\"font-size:12.0pt;\">Zinc deficiency</span></p>"
      },
      {
        "id": 229766,
        "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency</span></p>"
      },
      {
        "id": 229767,
        "text": "<p><span style=\"font-size:12.0pt;\">Selenium deficiency</span></p>"
      },
      {
        "id": 229768,
        "text": "<p><span style=\"font-size:12.0pt;\">Copper deficiency</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A child presented to PHC OPD with skin rash and depigmented hair. He gives a history of swollen/bleeding gums. X-ray picture is shown below. He is suffering from: (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174412.jpg\" alt=\"\" width=\"400\" height=\"284\"></span></p>",
    "unique_key": "Q1497190",
    "question_audio": null,
    "question_video": null,
    "map_id": 34306013,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Copper deficiency</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The clinical presentation of the child, including skin rash, depigmented hair, swollen/bleeding gums, and the X-ray findings, suggests a deficiency that closely mimics scurvy (vitamin C deficiency). However, in this question, the exact cause is copper deficiency, which shares similar symptoms and radiological appearances with scurvy. Copper plays a crucial role in various metabolic pathways, including those influenced by vitamin C, such as collagen synthesis and connective tissue health. Copper deficiency is known as pseudoscurvy because it presents with nearly identical clinical and radiological features as vitamin C deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Zinc deficiency: </strong>Zinc deficiency typically presents with symptoms such as delayed wound healing, immune dysfunction, and dermatitis, particularly around orifices. It does not cause the specific combination of bleeding gums, depigmented hair, and the radiological changes observed in the X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Iron deficiency: </strong>Iron deficiency usually presents with symptoms related to anemia, such as fatigue, pallor, and pica. While it can cause brittle nails and hair changes, it does not present with bleeding gums and specific X-ray findings as seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Selenium deficiency: </strong>Selenium deficiency primarily affects the heart and muscles, leading to conditions like Keshan disease (cardiomyopathy) and muscle weakness. It does not cause the bleeding gums, depigmented hair, or the bone abnormalities observed in the X-ray.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Copper deficiency can mimic vitamin C deficiency (scurvy) in its clinical and radiological presentation, a condition often referred to as pseudoscurvy.</span></p>",
    "correct_choice_id": 229768,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 11142,
    "choices": [
      {
        "id": 44534,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Screening of family members</span></p>"
      },
      {
        "id": 44535,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mobilization of resources</span></p>"
      },
      {
        "id": 44536,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Social support</span></p>"
      },
      {
        "id": 44537,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Interpersonal therapy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following elements is not included in the provisions of the Mental Health Care Act of 2017, as per the WHO's mhGAP? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q2335178",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305855,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Screening of family members</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The Mental Health Care Act, 2017 focuses on the rights and treatment of patients with mental illness, but it does not specifically include provisions for the screening of family members.</span></li><li><span style=\"font-size:12.0pt;\">The Act covers various aspects such as the capacity to make healthcare decisions, advance directives, nominated representatives, types of admissions, bans on certain treatments (like direct ECT for minors and psychosurgery), decriminalization of suicide attempts, and regulations on restraints and seclusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Mobilization of resources:</strong> The Act includes provisions related to the mobilization of resources for mental health services.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Social support:</strong> Social support is a crucial aspect of mental health care covered under the Act, ensuring that patients receive necessary support from family and community.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Interpersonal therapy:</strong> While specific therapies may not be explicitly listed, the Act does promote access to various mental health treatments, which can include interpersonal therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Screening of family members is not included in the Mental Health Care Act, 2017.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>MENTAL HEALTHCARE ACT, 2017 (MHCA 2017)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Deals with rights of patients with mental illness and treatment delivery. Important clauses-</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A. Capacity to make mental healthcare and treatment decision- Every person, including patients with mental illness, are assumed to have it if they can-</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Can understand the information provided to them</span></li><li><span style=\"font-size:12.0pt;\">Understand the consequences of their decisions</span></li><li><span style=\"font-size:12.0pt;\">Can communicate their decision</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">B. Advance directive- Every person (not a minor) can make an advance directive in which he can mention-</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">How they wish to be treated/not treated for a mental illness</span></li><li><span style=\"font-size:12.0pt;\">Applicable only if a person loses the capacity to take mental healthcare or treatment decisions</span></li><li><span style=\"font-size:12.0pt;\">Duty of psychiatrist (or medical officer) to give treatment according to the advance directive</span></li><li><span style=\"font-size:12.0pt;\">Doctor is not liable in case of unforeseen consequences while following the advance directive</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">C. Nominated representative (NR)-</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Every person can appoint a nominated representative</span></li><li><span style=\"font-size:12.0pt;\">In case of loss of capacity to make mental healthcare and treatment decision, NR would help in taking decisions about treatment</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">D. Admission- MHCA 2017 allows two types of admissions</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Independent admissions- When the patient himself wants to get admitted</span></li><li><span style=\"font-size:12.0pt;\">Supported admission (for a maximum of 30 days)- A person who has lost the capacity to make mental healthcare or treatment decisions and requires significant support from a nominated representative can be admitted under a \u201csupported admission\u201d</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">E. Ban on direct ECT</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">F. Ban on ECT for minors</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">G. Ban on psychosurgery</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">H. Decriminalisation of suicide attempt - Any person who attempts suicide shall be presumed to be under severe stress and should not be tried or punished</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">I. Restraints and seclusions - A patient can be physically restrained only-</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">If it is the only way to prevent harm to self or others</span></li><li><span style=\"font-size:12.0pt;\">If authorised by a psychiatrist in charge</span></li></ul>",
    "correct_choice_id": 44534,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11091,
    "choices": [
      {
        "id": 44330,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Only 1</span></span></span></p>"
      },
      {
        "id": 44331,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1 and 2</span></span></span></p>"
      },
      {
        "id": 44332,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 2, and 3</span></span></span></p>"
      },
      {
        "id": 44333,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 2, 3, and 4</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following statements accurately describe the operation and management of Mobile Medical Units (MMUs)? (INICET MAY 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MMUs are run by the government</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MMUs are run by external agencies with medical supplies given by the government.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MMUs are run by the government and medical supplies are also given by the government.</span></span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MMUs are run by external agencies and medical supplies are also given by the external agency.</span></span></li>\r\n</ol>",
    "unique_key": "Q2160858",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305885,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) 1, 2, and 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MMUs can be operated by either the Government or an external agency; however, the availability of drugs and medical supplies is exclusively the responsibility of the Government.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mobile Medical Units (MMU) represents a significant project within NRHM, aimed at delivering a variety of healthcare services to individuals residing in distant, hard-to-reach, unserved, and underserved regions, encompassing both rural and urban locations. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The goal is to bring essential healthcare services directly to the residents in these areas.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">There are 3 models of operationalizing MMUs:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Government operated MMU</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MMU operation is outsourced to an external agency, while the government covers capital expenses, medication, and supplies.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">External agency outsourcing includes both capital and operational expenses for MMUs.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The government is responsible for providing medication and supplies. MMUs offer essential primary healthcare services for prevalent illnesses (both communicable and non-communicable), reproductive and child health (RCH) services, screening examinations, and necessary referrals to advanced facilities and specialists. Medical Officer-led clinical services are delivered by a team, while mobilization and outreach activities are undertaken by ANMs and ASHA personnel.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Services and Resources of MMUs:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MMUs offer a variety of services, including primary care for common diseases, reproductive and child health services, diagnostic screenings, and referrals to specialized care.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">They are equipped with facilities for basic diagnostic tests such as blood glucose monitoring, pregnancy testing, and sputum sample collection, among others.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Human resources typically include a medical officer, a nurse, a lab technician, a pharmacist/administrative assistant, and a driver/support staff.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 44332,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11085,
    "choices": [
      {
        "id": 44306,
        "text": "<p><span style=\"font-size:12.0pt;\">\u20b9 500 is given per week</span></p>"
      },
      {
        "id": 44307,
        "text": "<p><span style=\"font-size:12.0pt;\">\u20b9 500 is given per month</span></p>"
      },
      {
        "id": 44308,
        "text": "<p><span style=\"font-size:12.0pt;\">Mid-day meals are given</span></p>"
      },
      {
        "id": 44309,
        "text": "<p><span style=\"font-size:12.0pt;\">Dietary advice is given</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient diagnosed with tuberculosis is learning about available government support for nutritional aid during treatment. Which of the following accurately represents a feature of the Nikshay Poshan Yojana? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q1734753",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305824,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) </strong>\u20b9 <strong>500 is given per month</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Nikshay Poshan Yojana provides nutritional support in the form of money to patients of TB.</span></li><li><span style=\"font-size:12.0pt;\">Patients receive \u20b9 500 per month under this scheme.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Nikshay Poshan Yojana:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Financial incentive of Rs 500/- per month for each notified TB patient for duration for which the patient is on anti-TB treatment</span></li><li><span style=\"font-size:12.0pt;\">All TB patients notified on or after 1st April 2018 including all existing TB patients under treatment are eligible to receive incentive</span></li></ul>",
    "correct_choice_id": 44307,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11130,
    "choices": [
      {
        "id": 44486,
        "text": "<p><span style=\"font-size:12.0pt;\">It confirms that the person does not have the disease</span></p>"
      },
      {
        "id": 44487,
        "text": "<p><span style=\"font-size:12.0pt;\">It suggests that if the disease is rare, the person surely has the disease</span></p>"
      },
      {
        "id": 44488,
        "text": "<p><span style=\"font-size:12.0pt;\">It confirms that the person has the disease if the disease is common</span></p>"
      },
      {
        "id": 44489,
        "text": "<p><span style=\"font-size:12.0pt;\">It is an expected finding in case the disease is prevalent</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A sensitive diagnostic test for a certain disease returns a positive result for a patient. What statement accurately describes the significance of a positive result from the sensitive test? (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q8472145",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305840,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) It confirms that the person has the disease if the disease is common</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">If a sensitive test yields a positive result, it indicates the presence of the disease, especially when the disease is prevalent.</span></li><li><span style=\"font-size:12.0pt;\">The sensitivity of a screening test refers to its capacity to accurately identify individuals with the disease.</span></li><li><span style=\"font-size:12.0pt;\">In simpler terms, sensitivity measures the test's capability to correctly spot true positives (TP) among all cases of the disease (TP+FN).&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sensitivity = TP / TP + FN X 100</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It confirms that the person does not have the disease:&nbsp;</strong>Incorrect. A sensitive test returning a positive result indicates the presence, not the absence, of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It suggests that if the disease is rare, the person surely has the disease:&nbsp;</strong>Incorrect. If the disease is rare, the positive predictive value (PPV) might be low, and the result may be less reliable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It is an expected finding in case the disease is prevalent:&nbsp;</strong>Incorrect. While a positive result is more likely in a prevalent disease, it does not solely rely on sensitivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A positive result from a highly sensitive test confirms the presence of the disease, particularly when the disease is common.</span></li></ul>",
    "correct_choice_id": 44488,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual"
    ]
  },
  {
    "id": 11166,
    "choices": [
      {
        "id": 44630,
        "text": "<p><span style=\"font-size:12.0pt;\">Single male migrants</span></p>"
      },
      {
        "id": 44631,
        "text": "<p><span style=\"font-size:12.0pt;\">Truck drivers</span></p>"
      },
      {
        "id": 44632,
        "text": "<p><span style=\"font-size:12.0pt;\">STD clinic attendees</span></p>"
      },
      {
        "id": 44633,
        "text": "<p><span style=\"font-size:12.0pt;\">Antenatal woman</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A public health officer is reviewing populations targeted by the HIV sentinel surveillance program. Which group is NOT traditionally included in HIV sentinel surveillance? (INICET NOV 2020)</span></p>",
    "unique_key": "Q1452009",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305879,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) STD clinic attendees</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Routine monitoring for HIV is generally not conducted among individuals visiting STD clinics.</span></li><li><span style=\"font-size:12.0pt;\">Sentinel surveillance serves to enhance the existing notification systems employed for disease surveillance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Single male migrants:</strong> Included in sentinel surveillance as they are considered at high risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Truck drivers:</strong> Included due to their high-risk behavior.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Antenatal women:</strong> Included to monitor HIV prevalence among pregnant women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The sites for HIV sentinel surveillance includes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A pregnant woman of reproductive age and attending the antenatal clinic for the first time.</span></li><li><span style=\"font-size:12.0pt;\">Female sex workers.</span></li><li><span style=\"font-size:12.0pt;\">Hijra/Transgenders.</span></li><li><span style=\"font-size:12.0pt;\">IV drug users</span></li><li><span style=\"font-size:12.0pt;\">Truckers.</span></li><li><span style=\"font-size:12.0pt;\">Homosexual Men</span></li><li><span style=\"font-size:12.0pt;\">Migrants.</span></li></ul>",
    "correct_choice_id": 44632,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11149,
    "choices": [
      {
        "id": 44562,
        "text": "<p><span style=\"font-size:12.0pt;\">Washing hands with soap and water</span></p>"
      },
      {
        "id": 44563,
        "text": "<p><span style=\"font-size:12.0pt;\">Administration of tenofovir monotherapy</span></p>"
      },
      {
        "id": 44564,
        "text": "<p><span style=\"font-size:12.0pt;\">Measure baseline viral markers of health care worker immediately</span></p>"
      },
      {
        "id": 44565,
        "text": "<p><span style=\"font-size:12.0pt;\">Measure viral markers after 6 weeks</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">During a busy day at the outpatient clinic, a nurse accidentally sustains a needle stick injury while drawing blood from a patient known to have HIV. She asks for guidance on immediate management steps to mitigate her risk of acquiring the infection. Which of the following recommendations would NOT be appropriate? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q6809881",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305862,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Administration of tenofovir monotherapy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Triple drug PEP regimens are now the recommended regimens for all exposures owing to the safety and tolerability of new HIV drugs. Tenofovir 300mg + Lamivudine 300mg + Dolutegravir 50mg is recommended for HIV post-exposure prophylaxis (PEP), not monotherapy.</span></li><li><span style=\"font-size:12.0pt;\">Post-exposure prophylaxis for HIV consists of a comprehensive set of services to prevent infection developing in an exposed person, including first aid care; counselling and risk assessment; HIV testing and counselling; and, depending on the risk assessment, the short term (28 days) provision of antiretroviral drugs, with support and follow-up.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Washing hands with soap and water:&nbsp;</strong>This is an appropriate initial step.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Measure baseline viral markers of health care worker immediately:&nbsp;</strong>This is necessary to establish the baseline and monitor for any seroconversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Measure viral markers after 6 weeks:&nbsp;</strong>Follow-up testing is crucial to detect any potential infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">For needle stick injuries involving HIV exposure, a triple drug regimen for post-exposure prophylaxis is recommended, not monotherapy.</span></li><li><span style=\"font-size:12.0pt;\">Immediate washing, baseline viral markers, and follow-up testing are also critical components of the management protocol.</span></li></ul>",
    "correct_choice_id": 44563,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 11168,
    "choices": [
      {
        "id": 44638,
        "text": "<p><span style=\"font-size:12.0pt;\">Cohort study</span></p>"
      },
      {
        "id": 44639,
        "text": "<p><span style=\"font-size:12.0pt;\">Systematic review</span></p>"
      },
      {
        "id": 44640,
        "text": "<p><span style=\"font-size:12.0pt;\">Meta-analysis</span></p>"
      },
      {
        "id": 44641,
        "text": "<p><span style=\"font-size:12.0pt;\">RCT</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You are a researcher aiming to compile and analyze data from various independent studies to enhance the precision of treatment effect estimates for a specific medical condition. Which of the following methodologies is most appropriate for achieving this objective? (INICET NOV 2020)</span></p>",
    "unique_key": "Q1875170",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305881,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Meta-analysis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Preference of epidemiological studies for establishing causality:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">1st preference: Meta-analysis</span></li><li><span style=\"font-size:12.0pt;\">2nd preference: Randomised controlled trials (RCTs)</span></li><li><span style=\"font-size:12.0pt;\">3rd preference: Retrospective (Non-concurrent/ Historical) cohort study</span></li><li><span style=\"font-size:12.0pt;\">4th preference: Prospective cohort study (Concurrent cohort study)</span></li><li><span style=\"font-size:12.0pt;\">5th preference: Case control study</span></li><li><span style=\"font-size:12.0pt;\">6th preference: Cross-sectional study</span></li><li><span style=\"font-size:12.0pt;\">7th preference: Ecological study</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Meta-analysis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">An objective, systematic review that employs statistical methods to combine and summarize the results of several studies.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">A quantitative synthesis of all unbiased evidence, meant for summarizing large volume of data, establishing and determining the magnitude of an effect, and to increase power and precision of studies</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cohort study:</strong> Observational study design, not suitable for synthesizing data from multiple studies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Systematic review:</strong> Provides a qualitative synthesis of evidence but does not statistically combine results.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. RCT (Randomized Controlled Trial):</strong> Primary study design, not a method for combining results from multiple studies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Meta-analysis is the most effective quantitative approach for synthesizing data from multiple research studies to derive a more precise estimate of the treatment effect.</span></li><li><span style=\"font-size:12.0pt;\">Preference of epidemiological studies for establishing causality - 1st preference is - Meta-analysis</span></li></ul>",
    "correct_choice_id": 44640,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11083,
    "choices": [
      {
        "id": 44298,
        "text": "<p><span style=\"font-size:12.0pt;\">Maternal Deaths per 10,000 live births&nbsp;</span></p>"
      },
      {
        "id": 44299,
        "text": "<p><span style=\"font-size:12.0pt;\">Maternal Deaths per 100,000 live births&nbsp;</span></p>"
      },
      {
        "id": 44300,
        "text": "<p><span style=\"font-size:12.0pt;\">Maternal Deaths per 10,000 women in reproductive age group&nbsp;</span></p>"
      },
      {
        "id": 44301,
        "text": "<p><span style=\"font-size:12.0pt;\">Maternal Deaths per 100,000 women in reproductive age group</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Dr. Aishwarya, a public health official, is discussing the maternal health situation in a rural district of Uttar Pradesh at a Panchayat meeting. She emphasizes the importance of understanding the maternal mortality ratio (MMR) for her district. Which definition best describes the MMR? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q8123506",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305822,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Maternal Deaths per 100,000 live births&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">MMR is Maternal deaths expressed as per 100,000 live births.</span></li><li><span style=\"font-size:12.0pt;\">Maternal Mortality rate (MMR): Maternal deaths expressed as per 100,000 live births, where a \u2018maternal death\u2019 is defined as \u2018death of a woman while pregnant or during delivery or within 42 days (6 weeks) of termination of pregnancy, irrespective of duration or site of pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes\u2019.</span></li><li><span style=\"font-size:12.0pt;\">MMR is a ratio (Maternal mortality rate is a misnomer; MMR is not a rate)</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-144548.png\" alt=\"\" width=\"500\" height=\"55\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>MMR World: 216 per 100,000 live births; Causes of MMR (globally):</strong></span></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Hemorrhage (25%)</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Indirect causes (20%)</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Infection (15%)</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Unsafe abortion (13%)</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Eclampsia (12%)</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Obstructed labour (8%)</span></p></li><li><span style=\"font-size:12.0pt;\"><strong>MMR India: 97 per 100,000 live births [2023]; Causes of MMR (India) [SRS 2023]:</strong></span></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\"><strong>Hemorrhage (38%)</strong></span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Other conditions (34%)</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Sepsis (11%)</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Abortion (8%)</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Obstructed labour (5%)</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"font-size:12.0pt;\">Hypertensive disorders (5%)</span></p></li><li><span style=\"font-size:12.0pt;\"><strong>Maternal mortality rate (MMRate):</strong> Dividing the average annual number of maternal deaths in a population by the average number of women of reproductive age (typically those aged 15 to 49 years) who are alive during the observation period.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MMRate reflects not only the risk of maternal death per pregnancy or per birth, but also the level of fertility in a population</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">MMR is a crucial indicator of maternal health in a population, reflecting the risk of maternal death associated with childbirth and its management.</span></li><li><span style=\"font-size:12.0pt;\">It is typically expressed per 100,000 live births to provide a clear picture of maternal health risks and the effectiveness of health interventions aimed at reducing these risks in specific areas or populations.</span></li></ul>",
    "correct_choice_id": 44299,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11144,
    "choices": [
      {
        "id": 44542,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Women empowerment</span></p>"
      },
      {
        "id": 44543,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Human trafficking</span></p>"
      },
      {
        "id": 44544,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Juvenile delinquency</span></p>"
      },
      {
        "id": 44545,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Child sexual abuse</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following best represents the primary concern addressed by the POCSO Act? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q2337200",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305857,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) Child sexual abuse</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The POCSO Act (Protection of Children from Sexual Offences Act) 2012 is designed to protect children under the age of 18 from sexual abuse and exploitation.</span></li><li><span style=\"font-size:12.0pt;\">It includes provisions for punishment of various offenses such as penetrative sexual assault, aggravated penetrative sexual assault, sexual assault, aggravated sexual assault, sexual harassment, and the use of children for pornography.</span></li><li><span style=\"font-size:12.0pt;\">The act ensures stringent punishment for offenders to provide a safe and secure environment for children.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Women empowerment:</strong> Incorrect. The POCSO Act is focused on protecting children from sexual offenses, not specifically on women empowerment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Human trafficking:</strong> Incorrect. While important, human trafficking is not the primary focus of the POCSO Act.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Juvenile delinquency:</strong> Incorrect. The act deals with protecting children from sexual offenses, not addressing juvenile delinquency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">POCSO Act (Prevention of Children from Sexual Offences Act) 2012</span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Child definition: Any person less than 18 years of age</span></li><li><span style=\"color:black;font-size:12.0pt;\">Includes: Sexual abuses and pornography</span></li><li><span style=\"color:black;font-size:12.0pt;\">Punishments under the act:&nbsp;&nbsp;</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-121427.png\" alt=\"\" width=\"1000\" height=\"385\"></p>",
    "correct_choice_id": 44545,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11087,
    "choices": [
      {
        "id": 44314,
        "text": "<p><span style=\"font-size:12.0pt;\">Congenital cataract</span></p>"
      },
      {
        "id": 44315,
        "text": "<p><span style=\"font-size:12.0pt;\">Congenital glaucoma</span></p>"
      },
      {
        "id": 44316,
        "text": "<p><span style=\"font-size:12.0pt;\">Retinopathy of prematurity</span></p>"
      },
      {
        "id": 44317,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A deficiency</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Dr. Sharma, the head of the pediatric department at a renowned medical college in Uttar Pradesh, is conducting a training session for new medical officers. As part of the session, he aims to ensure the officers are well-versed with the national health programs related to child health. He poses the question, \"Under the Rashtriya Bal Swashthya Karyakram (RBSK) initiative, which of these diseases is not covered? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q7364055",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305826,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Congenital glaucoma</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">While congenital cataract is explicitly mentioned as part of the initiative's coverage, congenital glaucoma is not typically listed among the prioritized conditions for screening under the RBSK.</span></li><li><span style=\"font-size:12.0pt;\">This omission might be due to the relative rarity or specific screening requirements of congenital glaucoma compared to more commonly addressed conditions in public health programs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Rashtriya Bal Swasthya Karyakram (RBSK)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><i>Importance</i>: Child Health Screening and Early Intervention Services Program under National Rural Health Mission</span></li><li><span style=\"font-size:12.0pt;\">Target group:</span><ul><li><span style=\"font-size:12.0pt;\">0-6 years old children (Rural areas + Urban slums)</span></li><li><span style=\"font-size:12.0pt;\">6-18 years old children (Enrolled in government schools)</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Targeted diseases (<strong>4D\u2019s</strong>):</span><ul><li><span style=\"font-size:12.0pt;\">Defects at birth</span></li><li><span style=\"font-size:12.0pt;\">Diseases in children</span></li><li><span style=\"font-size:12.0pt;\">Deficiency conditions</span></li><li><span style=\"font-size:12.0pt;\">Developmental delays including disabilities</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Targeted diseases:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-193311.jpg\" alt=\"\" width=\"800\" height=\"635\"></span></p>",
    "correct_choice_id": 44315,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 11146,
    "choices": [
      {
        "id": 44550,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Liposomal Amphotericin B</span></p>"
      },
      {
        "id": 44551,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Fluconazole</span></p>"
      },
      {
        "id": 44552,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Linezolid</span></p>"
      },
      {
        "id": 44553,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Bedaquiline</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">A 38-year-old man from a rural area of Bihar presents to the outpatient department of a tertiary care hospital in Patna. He has been experiencing fever for the past week, associated with abdominal distension, loss of appetite, and palpable lymphadenopathy. Despite being treated with broad-spectrum antibiotics and antimalarial agents by a local practitioner, there's been no significant relief. Blood investigations for typhoid (Widal test) are negative; however, the rk39 dipstick test is positive. Based on the clinical picture and the diagnostic findings, what would be the most appropriate drug of choice for the treatment of his condition?&nbsp;</span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2018)</span></p>",
    "unique_key": "Q5035505",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305859,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) Liposomal Amphotericin B</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">This clinical presentation strongly indicates the diagnosis of visceral leishmaniasis.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The recommended course of action for this patient involves the administration of liposomal amphotericin B.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-121923.png\" alt=\"\" width=\"1000\" height=\"305\"></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Incubation Period: 10 days to 2 years (average 1 \u2013 4 months)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Serological tests:</span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">ELISA: for diagnosis as well as epidemiological field survey</span></li><li><span style=\"color:black;font-size:12.0pt;\">rk 39 dipstick test</span></li><li><span style=\"color:black;font-size:12.0pt;\">Indirect Flourescent Antibody Test (IFAT)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Direct Agglutination Test</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">&nbsp;Treatment of Leishmaniasis</span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Sodium stibogluconate</span></li><li><span style=\"color:black;font-size:12.0pt;\">Miltefosine</span></li><li><span style=\"color:black;font-size:12.0pt;\">Paramomycin</span></li><li><span style=\"color:black;font-size:12.0pt;\">Liposomal Amphotericin B (DOC)</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option B</strong>: Fluconazole is an anti-fungal, not useful in visceral leishmaniasis</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option C</strong>: Linezolid is used in the treatment of MRSA</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option D</strong>: Bedaquiline is a newer anti-TB drug used in MDR-TB.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Visceral leishmaniasis (Kala Azar) should be treated with liposomal amphotericin B, especially when diagnosed with a positive rk39 dipstick test.</span></li></ul>",
    "correct_choice_id": 44550,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 11151,
    "choices": [
      {
        "id": 44570,
        "text": "<p><span style=\"font-size:12.0pt;\">Direct observation with a structured checklist</span></p>"
      },
      {
        "id": 44571,
        "text": "<p><span style=\"font-size:12.0pt;\">Closed circuit camera surveillance</span></p>"
      },
      {
        "id": 44572,
        "text": "<p><span style=\"font-size:12.0pt;\">In-depth interview with the patient</span></p>"
      },
      {
        "id": 44573,
        "text": "<p><span style=\"font-size:12.0pt;\">In-depth interview with the healthcare provider</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A newly established hospital aims to maintain the highest standards of care and ensure patient safety by standardizing injection practices among health workers. They seek a reliable method for real-time assessment of these practices. Which of the following would be the most appropriate method to monitor the injection practices of health workers? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q6037817",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305864,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Direct observation with a structured checklist</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The most effective approach for assessing the injection practices of healthcare workers is through direct observation using a structured checklist.</span></li><li><span style=\"font-size:12.0pt;\">This method allows for real-time, accurate assessment of adherence to aseptic techniques and best practices.</span></li><li><span style=\"font-size:12.0pt;\">A structured checklist ensures all critical steps are monitored and recorded systematically.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Closed circuit camera surveillance:&nbsp;</strong>While it may offer some insights, it lacks the detail and real-time assessment provided by direct observation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. In-depth interview with the patient:&nbsp;</strong>Patients may not have the expertise to accurately comment on the technical aspects of injection practices.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. In-depth interview with the healthcare provider:&nbsp;</strong>This relies on self-reporting, which may be biased and not always accurate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The most effective approach for assessing the injection practices of healthcare workers is through direct observation using a structured checklist.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-104556.png\" alt=\"\" width=\"1000\" height=\"874\"></p>",
    "correct_choice_id": 44570,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11141,
    "choices": [
      {
        "id": 44530,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Triage</span></p>"
      },
      {
        "id": 44531,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Consent for study participation</span></p>"
      },
      {
        "id": 44532,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hospital infection control</span></p>"
      },
      {
        "id": 44533,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Breaking bad news</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">During your residency, you learn about a specific protocol essential for physicians when dealing with challenging scenarios. This protocol, known as the SPIKES protocol, serves a unique purpose in medical communication. Can you identify the primary objective of employing the SPIKES protocol? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q7304345",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305854,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) Breaking bad news</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">SPIKES PROTOCOL</span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Communication of cancer Diagnosis &amp; Prognosis (or any adverse outcome)</span></li><li><span style=\"color:black;font-size:12.0pt;\"><strong>Protocol of 6 steps</strong></span></li></ul><p style=\"margin-left:48px;\"><span style=\"color:black;font-size:12.0pt;\">S - Set up interview</span></p><p style=\"margin-left:48px;\"><span style=\"color:black;font-size:12.0pt;\">P - Perceptions</span></p><p style=\"margin-left:48px;\"><span style=\"color:black;font-size:12.0pt;\">I - Invitation to explain</span></p><p style=\"margin-left:48px;\"><span style=\"color:black;font-size:12.0pt;\">K - Knowledge</span></p><p style=\"margin-left:48px;\"><span style=\"color:black;font-size:12.0pt;\">E - Emotions</span></p><p style=\"margin-left:48px;\"><span style=\"color:black;font-size:12.0pt;\">S - Summary &amp; Strategy</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Best used for Communication of diagnosis and prognosis for Breast Cancer</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Triage:</strong> Incorrect. Triage involves prioritizing patient care based on the severity of their condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Consent for study participation:</strong> Incorrect. Obtaining consent for study participation requires a different communication protocol focused on informed consent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hospital infection control:</strong> Incorrect. Infection control involves protocols for preventing and managing infections within the hospital setting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The SPIKES protocol is specifically designed to guide physicians in breaking bad news to patients, ensuring the communication is handled with sensitivity and clarity.</span></li></ul>",
    "correct_choice_id": 44533,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 11167,
    "choices": [
      {
        "id": 44634,
        "text": "<p><span style=\"font-size:12.0pt;\">FeSO4 + Vit C + Folate + Vit B12</span></p>"
      },
      {
        "id": 44635,
        "text": "<p><span style=\"font-size:12.0pt;\">Iron (III) hydroxide polymaltose</span></p>"
      },
      {
        "id": 44636,
        "text": "<p><span style=\"font-size:12.0pt;\">Ferrous fumarate</span></p>"
      },
      {
        "id": 44637,
        "text": "<p><span style=\"font-size:12.0pt;\">Inj. iron sucrose</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You work as a medical officer in a Primary Health Center (PHC). You are tasked with developing a strategy to address widespread anemia in the community. Considering the need for efficacy, safety, and ease of administration, which of the following options would you recommend for the prevention and treatment of anemia in this setting? (INICET NOV 2020)</span></p>",
    "unique_key": "Q6223770",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305880,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) FeSO4 + Vit C + Folate + Vit B12</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Among the given options, FeSO4 + vitamin C + Folate + vitamin B12 is likely to be the best mass prophylaxis against anemia.</span></li><li><span style=\"font-size:12.0pt;\">Vit C enhances the absorption of iron from the stomach by acting as a reducing substance.</span></li><li><span style=\"font-size:12.0pt;\">Supplementing vitamin B12 can reduce incidence and prevalence of megaloblastic anemia as cost factor is not that significant.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Iron (III) hydroxide polymaltose:</strong> It is not yet evident to be more efficacious than FeSO4</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ferrous fumarate:</strong> It is considered to be equally efficacious but vitamin C as an adjunct improves absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Injection iron sucrose:</strong> Injection iron sucrose or any parenteral form is a first-line option. It is only indicated if the oral form is not tolerated or patient is not compliant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The comprehensive and cost-effective approach, including FeSO4 + Vitamin C + Folate + Vitamin B12, is preferable for the widespread prevention and treatment of anemia in a community setting, especially in a resource-limited Primary Health Center (PHC).</span></li></ul>",
    "correct_choice_id": 44634,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 11138,
    "choices": [
      {
        "id": 44518,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mean = mode = median</span></p>"
      },
      {
        "id": 44519,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mean = median, not equal to mode</span></p>"
      },
      {
        "id": 44520,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mean, median, mode not equal</span></p>"
      },
      {
        "id": 44521,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mode = median, not equal to mean</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The image shows two data distribution curves from separate studies within the same population: one depicted with a red line and the other with a blue line. Given the graphical representation, which of the following correctly represents the relationship among the mean, median, and mode for the data presented? (AIIMS NOV 2018)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip39.jpg\" alt=\"\" width=\"300\" height=\"223\"></p>",
    "unique_key": "Q4589721",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305851,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Mean = median, not equal to mode</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Analyzing the two graphs, we observe different distribution patterns:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Red line (Study A):</strong> The distribution is unimodal and symmetrical, indicating that the mean, median, and mode are all equal.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Blue line (Study B):</strong> The distribution is bimodal, showing two distinct peaks. In a bimodal distribution, the mean and median are typically equal, but there are two modes, making the mode not equal to the mean or median.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a bimodal distribution, the mean and median can be equal, but the mode will not be equal to them, as there are two modes.</span></p>",
    "correct_choice_id": 44519,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 11122,
    "choices": [
      {
        "id": 44454,
        "text": "<p><span style=\"font-size:12.0pt;\">Not rejecting a null hypothesis when it is true</span></p>"
      },
      {
        "id": 44455,
        "text": "<p><span style=\"font-size:12.0pt;\">Rejecting a null hypothesis when it is true</span></p>"
      },
      {
        "id": 44456,
        "text": "<p><span style=\"font-size:12.0pt;\">Not rejecting a null hypothesis when it is false</span></p>"
      },
      {
        "id": 44457,
        "text": "<p><span style=\"font-size:12.0pt;\">Rejecting a null hypothesis when it is false</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A researcher is analyzing the results of a study comparing two antihypertensive drugs in an Indian population. She comes across the term \"p-value\" in her statistical analyses. Which of the following best describes the interpretation of a p-value with regard to the probability related to the null hypothesis? (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q2377881",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305832,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Rejecting a null hypothesis when it is true</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The p-value represents the likelihood of mistakenly rejecting a true null hypothesis. It serves as the threshold for determining statistical significance.</span></li><li><span style=\"font-size:12.0pt;\">In essence, the p-value signifies the probability of erroneously rejecting a valid null hypothesis, leading to a Type I error.</span></li></ul><p style=\"margin-left:9px;\">&nbsp;</p><p style=\"margin-left:9px;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:9px;\">&nbsp;</p><p style=\"margin-left:9px;\"><span style=\"font-size:12.0pt;\"><strong>Option A. Not rejecting a null hypothesis when it is true:</strong> This describes a correct decision where the null hypothesis is true, and the researcher correctly decides not to reject it. This scenario does not involve a p-value interpretation.</span></p><p style=\"margin-left:9px;\">&nbsp;</p><p style=\"margin-left:9px;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Not rejecting a null hypothesis when it is false:</strong> This describes a Type II error, where the null hypothesis is false, but the researcher fails to reject it. The p-value is not directly related to this scenario.</span></p><p style=\"margin-left:9px;\">&nbsp;</p><p style=\"margin-left:9px;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Rejecting a null hypothesis when it is false:</strong> This describes a correct decision where the null hypothesis is false, and the researcher correctly rejects it. This is the goal of hypothesis testing but not the specific interpretation of a p-value.</span></p><p style=\"margin-left:9px;\">&nbsp;</p><p style=\"margin-left:9px;\"><span style=\"font-size:12.0pt;\"><strong>Null Hypothesis</strong></span></p><p style=\"margin-left:9px;\">&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Hypothesis (H): Is an assumption about the status of a phenomenon</span></li><li><span style=\"font-size:12.0pt;\">Null Hypothesis (H0): In Biostatistics, when we have to prove a particular hypothesis about difference between 2 regimens, we make Null Hypothesis (For examples, If we have to prove that new treatment is better than older treatment, H0 = new treatment is not better than older treatment).</span></li></ul>",
    "correct_choice_id": 44455,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 57605,
    "choices": [
      {
        "id": 229789,
        "text": "<p><span style=\"font-size:12.0pt;\">2 5 4 3 1</span></p>"
      },
      {
        "id": 229790,
        "text": "<p><span style=\"font-size:12.0pt;\">1 2 3 4 5</span></p>"
      },
      {
        "id": 229791,
        "text": "<p><span style=\"font-size:12.0pt;\">2 4 5 1 3</span></p>"
      },
      {
        "id": 229792,
        "text": "<p><span style=\"font-size:12.0pt;\">1 2 4 5 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Arrange the steps of the Demographic cycle in the correct chronological sequence: (NEET PG 2024)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Low stationary</span></li><li><span style=\"font-size:12.0pt;\">High stationary</span></li><li><span style=\"font-size:12.0pt;\">Declining</span></li><li><span style=\"font-size:12.0pt;\">Early expanding</span></li><li><span style=\"font-size:12.0pt;\">Late expanding</span></li></ol>",
    "unique_key": "Q9278936",
    "question_audio": null,
    "question_video": null,
    "map_id": 34306007,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 2 4 5 1 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Demographic Transition Model describes the stages a country goes through as it transitions from high birth and death rates to low birth and death rates. The stages of the demographic cycle in correct chronological order are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. High Stationary :</strong> This is the first stage characterized by high birth and high death rates, leading to a stable population. It reflects pre-industrial societies with limited medical care and poor living conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Early Expanding:</strong> In this stage, death rates start to decline due to improvements in healthcare, sanitation, and nutrition, while birth rates remain high, resulting in rapid population growth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>5. Late Expanding :</strong> Birth rates begin to fall as societies become more urbanized and access to contraception improves, but the population continues to grow, albeit at a slower rate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Low Stationary :</strong> Both birth and death rates are low, stabilizing the population size. This stage reflects advanced economies with high living standards and access to family planning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Declining :</strong> In the final stage, the birth rate falls below the death rate, leading to a declining population. This stage is seen in highly developed countries with aging populations and very low fertility rates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct sequence of the demographic cycle stages is: High Stationary, Early Expanding, Late Expanding, Low Stationary, and Declining.</span></p>",
    "correct_choice_id": 229791,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11163,
    "choices": [
      {
        "id": 44618,
        "text": "<p><span style=\"font-size:12.0pt;\">Student t test</span></p>"
      },
      {
        "id": 44619,
        "text": "<p><span style=\"font-size:12.0pt;\">Friedman test</span></p>"
      },
      {
        "id": 44620,
        "text": "<p><span style=\"font-size:12.0pt;\">ANOVA</span></p>"
      },
      {
        "id": 44621,
        "text": "<p><span style=\"font-size:12.0pt;\">Pearson</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A researcher is comparing the means of three different groups with non-normally distributed data and small sample sizes. Which of the following tests is best suited for analyzing this non-parametric data? (INICET NOV 2020)</span></p>",
    "unique_key": "Q6353477",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305876,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Friedman test</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Friedman test is a non-parametric statistical test used for detecting differences in treatments across multiple test attempts.</span></li><li><span style=\"font-size:12.0pt;\">It is the equivalent of a one-way ANOVA with repeated measures but for non-parametric data.</span></li><li><span style=\"font-size:12.0pt;\">Since the data in this scenario is not normally distributed, and the groups are related, the Friedman test is the appropriate choice.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/30/screenshot-2023-10-30-113543.jpg\" alt=\"\" width=\"1000\" height=\"453\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Student t-test:</strong> Student t-test is used for comparing the means of two groups. However, it assumes that the data is normally distributed.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. ANOVA:</strong> ANOVA (Analysis of Variance) is used for comparing the means of three or more independent groups.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pearson:</strong> Pearson correlation is used for measuring the strength of a linear association between two quantitative variables. It is not a test for comparing means and also assumes a normal distribution of the data.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Choose the Friedman test when you need to compare the means of three or more related groups, and the data is not normally distributed, ensuring accurate and reliable statistical analysis in non-parametric settings.</span></li></ul>",
    "correct_choice_id": 44619,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 57820,
    "choices": [
      {
        "id": 230641,
        "text": "<p><span style=\"font-size:12.0pt;\">EBM mandates that clinical decisions should exclusively rely on findings from high-quality randomized controlled trials, disregarding other forms of evidence.&nbsp;</span></p>"
      },
      {
        "id": 230642,
        "text": "<p><span style=\"font-size:12.0pt;\">EBM categorically negates the intrinsic value of accumulated clinical experience, positioning empirical research findings as the sole determinant of clinical practice.&nbsp;</span></p>"
      },
      {
        "id": 230643,
        "text": "<p><span style=\"font-size:12.0pt;\">EBM harmoniously amalgamates the clinician's individual expertise, accrued through years of practice, with the most robust and relevant external scientific evidence.&nbsp;</span></p>"
      },
      {
        "id": 230644,
        "text": "<p><span style=\"font-size:12.0pt;\">EBM emphasizes a dependency on recommendations primarily made by pharmaceutical companies, given their investment in large-scale research.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A recent medical graduate is attending a seminar on Evidence-Based Medicine (EBM). The speaker emphasizes EBM's integrative approach to patient care. Which statement most accurately encapsulates the core philosophy of EBM? (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q4990902",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305842,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;EBM harmoniously amalgamates the clinician's individual expertise, accrued through years of practice, with the most robust and relevant external scientific evidence</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It integrates individual clinical expertise with the best external clinical evidence.</span></li><li><span style=\"font-size:12.0pt;\">EBM is a combination of research evidence, clinical experience, and patient values/preferences.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-185116.png\" alt=\"\" width=\"300\" height=\"281\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Critical appraisal of research findings and&nbsp;decisions regarding whether, and how, to use&nbsp;findings in the care of patients</span></li></ul><p><br><br><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. EBM mandates that clinical decisions should exclusively rely on findings from high-quality randomized controlled trials, disregarding other forms of evidence:&nbsp;</strong>Incorrect. EBM values a combination of different types of evidence, including clinical expertise and patient preferences.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. EBM categorically negates the intrinsic value of accumulated clinical experience, positioning empirical research findings as the sole determinant of clinical practice:&nbsp;</strong>Incorrect. EBM values clinical experience alongside empirical research findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. EBM emphasizes a dependency on recommendations primarily made by pharmaceutical companies, given their investment in large-scale research:&nbsp;</strong>Incorrect. EBM focuses on unbiased, high-quality evidence rather than recommendations from potentially biased sources.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The core philosophy of Evidence-Based Medicine (EBM) is to integrate the clinician's expertise with the best available external evidence and patient values to make informed clinical decisions.</span></li></ul>",
    "correct_choice_id": 230643,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11140,
    "choices": [
      {
        "id": 44526,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Maternal deaths per 100 live births</span></p>"
      },
      {
        "id": 44527,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Maternal deaths per 10,000 live births</span></p>"
      },
      {
        "id": 44528,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Maternal deaths per 100,000 live births</span></p>"
      },
      {
        "id": 44529,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Maternal deaths per 1.000 live births</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The Maternal Mortality Ratio (MMR) is a critical parameter used to evaluate maternal health within countries. In the context of public health statistics, how is the Maternal Mortality Ratio (MMR) for a country conventionally expressed? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q1681522",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305853,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) Maternal deaths per 100,000 live births</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">MMR is Maternal deaths expressed as per 100,000 live births.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Maternal Mortality ratio (MMR): Maternal deaths expressed as per 100,000 live births, where a \u2018maternal death\u2019 is defined as \u2018death of a woman while pregnant or during delivery or within 42 days (6 weeks) of termination of pregnancy, irrespective of duration or site of pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes\u2019.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">MMR is a ratio&nbsp;</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture133355.jpg\" alt=\"\" width=\"700\" height=\"79\"></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The Maternal Mortality Ratio (MMR) is expressed as the number of maternal deaths per 100,000 live births, providing a measure of the safety and quality of maternal care in a country.</span></li></ul>",
    "correct_choice_id": 44528,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11088,
    "choices": [
      {
        "id": 44318,
        "text": "<p><span style=\"font-size:12.0pt;\">&gt;0.1 IU/ml</span></p>"
      },
      {
        "id": 44319,
        "text": "<p><span style=\"font-size:12.0pt;\">&gt;0.01 IU/ml</span></p>"
      },
      {
        "id": 44320,
        "text": "<p><span style=\"font-size:12.0pt;\">&gt;0.001 IU/ml</span></p>"
      },
      {
        "id": 44321,
        "text": "<p><span style=\"font-size:12.0pt;\">&gt;0.0001 IU/ml</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What concentration of tetanus antitoxin in the blood is considered clinically protective against tetanus? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q1313469",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305827,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) &gt;0.01 IU/ml</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Specific antibody concentrations greater than 0.01 IU/mL were considered protective against tetanus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Aim of active Immunisation with TT:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Vaccinate the entire community</span></li><li><span style=\"font-size:12.0pt;\">Ensure protective level of antitoxin ~ 0.01 IU/mL serum throughout life</span></li></ul>",
    "correct_choice_id": 44319,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11128,
    "choices": [
      {
        "id": 44478,
        "text": "<p><span style=\"font-size:12.0pt;\">Pandemic, endemic, sporadic</span></p>"
      },
      {
        "id": 44479,
        "text": "<p><span style=\"font-size:12.0pt;\">Sporadic, endemic, epidemic</span></p>"
      },
      {
        "id": 44480,
        "text": "<p><span style=\"font-size:12.0pt;\">Endemic, epidemic, sporadic</span></p>"
      },
      {
        "id": 44481,
        "text": "<p><span style=\"font-size:12.0pt;\">Endemic, sporadic, epidemic</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Dr. Geeta, a senior epidemiologist in Delhi, receives weekly updates on the prevalence of several diseases in the states/region she oversees. Recently, she noticed distinct patterns in three different diseases over a two-week period: (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Disease 1:&nbsp;</strong>Number of cases last week = 42, this week = 43</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Disease 2:&nbsp;</strong>Number of cases last week 2 and present week 42</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Disease 3:&nbsp;</strong>Number of cases last week 6 and present week 1</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">How should these diseases be categorized?</span></p>",
    "unique_key": "Q4520034",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305838,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Endemic, epidemic, sporadic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Disease 1 -&nbsp;</strong>The similarity of the cases suggests that it must be endemic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Disease 2 -&nbsp;</strong>The surge in case numbers is deeply concerning, suggesting the potential emergence of an epidemic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Disease 3 -&nbsp;</strong>The decrease in the number of cases has occurred without a clear explanation, suggesting that it may be sporadic in nature. An epidemic, on the other hand, is characterized by the occurrence of a disease at a rate exceeding the expected frequency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Endemic</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Constant presence of a disease or infectious agent in a defined geographical area. It is the usual or expected frequency\u2019 of a disease in a population</span></li><li><span style=\"font-size:12.0pt;\">Types of Endemic:</span></li><li><span style=\"font-size:12.0pt;\">Hyper-endemic: Constant presence of a disease or infectious agent at high incidence/prevalence AND affects all age groups equally</span></li><li><span style=\"font-size:12.0pt;\">Holo-endemic: A high level of infection beginning early in life AND affecting most of the children population</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Pandemic</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">An epidemic usually affecting a large proportion of the population, occurring over a large geographical area such as part of a nation, nation, continent or world (Country-to-country spread)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Sporadic</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Cases which are \u2018scattered about\u2019</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Cases are widely separated in space and time</span></li><li><span style=\"font-size:12.0pt;\">Show little or no connection with each other</span></li><li><span style=\"font-size:12.0pt;\">There is no recognizable source of infection</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Endemic diseases show a stable presence, epidemics show a sudden increase in cases, and sporadic diseases occur irregularly.</span></li></ul>",
    "correct_choice_id": 44480,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 76141,
    "choices": [
      {
        "id": 303437,
        "text": "<p><span style=\"font-size:16px;\">Yellow category</span></p>"
      },
      {
        "id": 303438,
        "text": "<p><span style=\"font-size:16px;\">Red category</span></p>"
      },
      {
        "id": 303439,
        "text": "<p><span style=\"font-size:16px;\">White category</span></p>"
      },
      {
        "id": 303440,
        "text": "<p><span style=\"font-size:16px;\">Blue category</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A cotton swab, pus stained, is disposed in which color of BMW management category?&nbsp;(INICET NOV 2024)</span></p>",
    "unique_key": "Q6272900",
    "question_audio": null,
    "question_video": null,
    "map_id": 34306016,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Yellow category</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">According to the latest BMW (Biomedical Waste Management) guidelines 2017-2018, biomedical waste is categorized into four main categories based on the type of waste and its disposal method<strong>. The yellow category includes human anatomical waste, animal waste, soiled waste (which includes cotton, gauge pieces, bandages, dressings), discarded medicines, and chemical waste.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Cotton swabs that are stained with pus are classified as soiled waste&nbsp;</strong>and therefore should be disposed of in the <strong>yellow category</strong>. The yellow category waste is typically disposed of through incineration (at 1200\u00b0C) or plasma pyrolysis. In some specific cases, especially at the <strong>PHC level, deep burial may also be used for certain types of yellow category waste.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Red category: Incorrect.&nbsp;</strong>The red category is meant for solid/contaminated (recyclable) waste including <strong>plastic and rubber items such as tubings, catheters, and cannulas</strong>.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gxk7c8C.png\" width=\"975\" height=\"269\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. White category: Incorrect.&nbsp;</strong>The white category is specifically designated for waste sharps such as <strong>needles, surgical blades, and scalpels</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2nYrpbd.png\" width=\"975\" height=\"308\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Blue category: Incorrect.&nbsp;</strong>The blue category is for <strong>glassware, orthopedic metallic body implants, and other items from ENT, dental, cardio-thoracic, and vascular surgery</strong>.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ViQxEww.png\" width=\"975\" height=\"190\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Cotton swabs stained with pus</strong> are classified as soiled waste and should be disposed of in the <strong>yellow category</strong> of biomedical waste management.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_56w3kap.png\" width=\"1022\" height=\"741\"></span></p>",
    "correct_choice_id": 303437,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11148,
    "choices": [
      {
        "id": 44558,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">197</span></span></span></span></p>"
      },
      {
        "id": 44559,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">392</span></span></span></span></p>"
      },
      {
        "id": 44560,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">225</span></span></span></span></p>"
      },
      {
        "id": 44561,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">344</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A community with a population of 20,000 documented 456 births in a year, of which 56 were stillbirths. The total number of deaths in the community for that year was 247, including 56 deaths within the first 28 days of life and 34 additional deaths after 28 days but before completing the first year of life. What is the infant mortality rate (IMR) for this community? (AIIMS NOV 2019)</span></span></p>",
    "unique_key": "Q4668530",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305861,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 225</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-161612.jpg\" style=\"height:64px; width:500px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the given question,</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> out of total 456 births, 56 were dead born.&nbsp;</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therefore, the number of live births= 456-56 = 400.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the same year, it is given that the number of deaths before 28 days is 56, and the number of deaths after 28 days but before 1 year is 34.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hence, the total number of deaths of children &lt; 1 year is 56 + 34 = 90</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IMR = (90x1000)/400 = 900/4 = 225</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hence, the IMR is 225 per 1000 live births.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INFANT MORTALITY RATE</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is the number of deaths per 1000 live births of children under one year of age. It is the most sensitive indicator of availability and utilization of health care services in a country. Is most important indicator of health status of a community, level of living and effectiveness of MCH services in general.&nbsp;</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IMR is among &lsquo;the best predictors of state failure&rsquo;</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a rate.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IMR of India (2023): 26.6 per 1000 live births;&nbsp;</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IMR of India - 35 per 1000 live births (NFHS-5 2019-21,);&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">28 per 1000 Live births (SRS, May 2022)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Is the second best indicator of socio-economic development of a country: Ultimate solution&nbsp;for lowering IMR lies in socio-economic development [Best indicator is U5MR]</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Infant Mortality Rate (IMR) for the community, calculated as the number of infant deaths per 1000 live births. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This rate serves as a crucial indicator of the health status and effectiveness of maternal and child health services in the community.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NOTE - UNICEF considers U5MR or CMR as &lsquo;single best indicator of socio-economic development and well-being&rsquo; (even better than IMR)</span></span></strong></span></span></p>",
    "correct_choice_id": 44560,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11129,
    "choices": [
      {
        "id": 44482,
        "text": "<p><span style=\"font-size:12.0pt;\">Point A</span></p>"
      },
      {
        "id": 44483,
        "text": "<p><span style=\"font-size:12.0pt;\">Point B</span></p>"
      },
      {
        "id": 44484,
        "text": "<p><span style=\"font-size:12.0pt;\">Point C</span></p>"
      },
      {
        "id": 44485,
        "text": "<p><span style=\"font-size:12.0pt;\">Point D</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A diagram illustrating the natural history of a disease has points marked A, B, C, and D. Which point indicates the onset of symptoms in the disease's natural history? (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip33.jpg\" alt=\"\" width=\"668\" height=\"261\"></span></p>",
    "unique_key": "Q2907843",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305839,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Point C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Point C:</strong> Marks onset of clinical signs and symptoms</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Point A:&nbsp;</strong>Entry of infectious agent into the host.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Point B:&nbsp;</strong>Pathological and physiological changes occur in the stage of the subclinical phase. These changes are induced by the causative agent but are not sufficient enough to cause clinical signs and symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Point D:&nbsp;</strong>Usual time of diagnosis at which clinical signs and symptoms are well evident.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip34.jpg\" alt=\"\" width=\"700\" height=\"311\"></p>",
    "correct_choice_id": 44484,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 57604,
    "choices": [
      {
        "id": 229785,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Up to 48 hours</span></span></span></p>"
      },
      {
        "id": 229786,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Up to 72 hours</span></span></span></p>"
      },
      {
        "id": 229787,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Up to 6 weeks</span></span></span></p>"
      },
      {
        "id": 229788,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Up to 12 weeks</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Preferable time for IUCD insertion in a 28-year-old woman who has just delivered a healthy newborn. It was a normal vaginal delivery.</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (NEET PG 2024)</span></span></p>",
    "unique_key": "Q5035238",
    "question_audio": null,
    "question_video": null,
    "map_id": 34306008,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Up to 48 hours</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intrauterine Contraceptive Device (IUCD) insertion timing can be categorized into three main periods:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">During Menstruation:</span></strong><span style=\"font-size:12.0pt\"> IUCD insertion during menstruation is <strong>preferred within the first 10 days </strong>of the menstrual cycle to ensure the woman is not pregnant and to ease insertion due to the open cervical os.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Immediate Postpartum:</span></strong><span style=\"font-size:12.0pt\"> The best time for postpartum IUCD insertion is <strong>within the first 48 hours after delivery.</strong> If not done within this window, insertion can be performed up to 1 week postpartum. This timing is optimal as the cervix is dilated, and there is a reduced risk of expulsion compared to later periods.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Post Puerperal:</span></strong><span style=\"font-size:12.0pt\"> If IUCD insertion is not performed immediately postpartum, the next preferred timing is <strong>6 to 8 weeks after delivery</strong> when the uterus has involuted and stabilized.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For this question, since the woman has just delivered, the most precise and preferred time is within the first 48 hours postpartum.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most preferable time for IUCD insertion after a normal vaginal delivery is within the first 48 hours postpartum to take advantage of the naturally dilated cervix and minimize expulsion risk</span></span></span></p>",
    "correct_choice_id": 229785,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11121,
    "choices": [
      {
        "id": 44450,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">DPT -1, OPV-1 only</span></span></span></p>"
      },
      {
        "id": 44451,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">BCG, DPT-1, OPV-1</span></span></span></p>"
      },
      {
        "id": 44452,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">BCG, DPT-1, OPV-1, Measles - 1, Vit. A -1</span></span></span></p>"
      },
      {
        "id": 44453,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">DPT-1, OPV-1, Measles - 1, Vit. A - 1</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pediatrician in a remote village encounters an 18-month-old child with no vaccination history. According to the National Immunization Schedule, which set of vaccines should the child receive? (AIIMS NOV 2017)</span></span></p>",
    "unique_key": "Q4065525",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305831,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">Ans. D) DPT-1, OPV-1, Measles -1, Vit. </span></strong><strong><span style=\"font-size:12.0pt\">A - 1</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to India&#39;s National Immunization Schedule (NIS), an 18-month-old child who has not received any immunizations should be given their initial doses of DPT, OPV, measles vaccine, and vitamin A.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Age Limits for Delayed Immunization in NIS, India</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture5.jpg\" style=\"height:468px; width:700px\" /></span></span></span></span></p>\r\n\r\n<p style=\"margin-left:9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Case studies&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:9px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture6.jpg\" style=\"height:406px; width:700px\" /></span></span></span></span></p>",
    "correct_choice_id": 44453,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 11158,
    "choices": [
      {
        "id": 44598,
        "text": "<p><span style=\"font-size:12.0pt;\">Post-neonatal period death</span></p>"
      },
      {
        "id": 44599,
        "text": "<p><span style=\"font-size:12.0pt;\">Early neonatal death of fetus &gt; 1000 g</span></p>"
      },
      {
        "id": 44600,
        "text": "<p><span style=\"font-size:12.0pt;\">Stillbirth of fetus &lt; 500 g</span></p>"
      },
      {
        "id": 44601,
        "text": "<p><span style=\"font-size:12.0pt;\">Abortion after 16 weeks</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">To accurately calculate the perinatal mortality rate, which of the following should specifically be considered as part of the numerator? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q9273881",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305871,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Early neonatal death of fetus &gt; 1000 g&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Perinatal Mortality Rate (PNMR)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It includes both late fetal deaths (stillbirths) and early neonatal deaths.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture8555.jpg\" alt=\"\" width=\"700\" height=\"82\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Perinatal period is from 28 weeks period of gestation to 7th&nbsp;completed days of life (But the WHO definition of perinatal period is from 22 completed weeks gestation to 7th completed days of life).</span></li><li><span style=\"font-size:12.0pt;\">PNMR is a major marker to assess the quality of health care delivery; PNMR is a\u201d Yardstick of Obstetric and Pediatric care before and around the time of birth\u201d</span></li><li><span style=\"font-size:12.0pt;\">P List (ICD 10): 100 causes of perinatal mortality and morbidity</span></li><li><span style=\"font-size:12.0pt;\">PNMR of India (2022) - 18 per 1000 LB (SRS, September 2022)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Perinatal mortality rate includes late fetal deaths (stillbirths) and early neonatal deaths, focusing on the period from 28 weeks of gestation to 7 days after birth.</span></li></ul>",
    "correct_choice_id": 44599,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 57598,
    "choices": [
      {
        "id": 229761,
        "text": "<p><span style=\"font-size:12.0pt;\">Nothing should be given</span></p>"
      },
      {
        "id": 229762,
        "text": "<p><span style=\"font-size:12.0pt;\">Penicillin</span></p>"
      },
      {
        "id": 229763,
        "text": "<p><span style=\"font-size:12.0pt;\">Diphtheria antitoxin</span></p>"
      },
      {
        "id": 229764,
        "text": "<p><span style=\"font-size:12.0pt;\">1 dose of DPT booster</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old girl has a greyish white membrane over tonsils and presented with bull-neck appearance. She has a 2-year-old brother who is fully immunized for his age. What should be given to the brother? (NEET PG 2024)</span></p>",
    "unique_key": "Q3774985",
    "question_audio": null,
    "question_video": null,
    "map_id": 34306014,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;</strong> <strong>A) Nothing should be given</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The 5-year-old girl shows clinical signs of diphtheria, characterized by a greyish white membrane over the tonsils and bull-neck appearance. The question asks about the appropriate management for her fully immunized 2-year-old brother, who is a close contact.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174329.jpg\" alt=\"\" width=\"400\" height=\"284\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>For contacts of a diphtheria case:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">If the contact (in this case, the brother) has received primary immunization or a booster within the last 2 years, no additional intervention is needed.</span></li><li><span style=\"font-size:12.0pt;\">If the immunization or booster was taken more than 2 years ago, then a booster dose is required to maintain protection.</span></li><li><span style=\"font-size:12.0pt;\">If the contact is completely unimmunized \u2013 Prophylactic t/t with Penicillin or Erythromycin along with 1000-2000 units Diphtheria antitoxin, and start immunization of contact</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Medical surveillance needs to be done daily and</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bacteriological surveillance \u2013 swabs on weekly basis&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Since the brother is fully immunized for his age, and presumably within the past 2 years, no additional treatment is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Penicillin:&nbsp; </strong>This is used as prophylactic treatment for contacts who are completely unimmunized. It is not indicated for those who are fully vaccinated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp; Diphtheria antitoxin</strong>: This is administered to unimmunized contacts for immediate passive immunity, especially when there is a high risk of exposure, but it is not required for fully immunized individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp; 1 dose of DPT booster:&nbsp;</strong> This is given if the last dose of primary immunization or booster was taken more than 2 years ago, but not needed if within the last 2 years.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In managing contacts of diphtheria, no additional doses are required if the contact has received primary immunization or booster within the last 2 years.</span></p>",
    "correct_choice_id": 229761,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11090,
    "choices": [
      {
        "id": 44326,
        "text": "<p><span style=\"font-size:12.0pt;\">Face mask</span></p>"
      },
      {
        "id": 44327,
        "text": "<p><span style=\"font-size:12.0pt;\">1% glutaraldehyde</span></p>"
      },
      {
        "id": 44328,
        "text": "<p><span style=\"font-size:12.0pt;\">70% alcohol</span></p>"
      },
      {
        "id": 44329,
        "text": "<p><span style=\"font-size:12.0pt;\">Hand washing</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">During a telemedicine session with patients in a rural health clinic, Dr. Reddy emphasized preventive measures for COVID-19. He highlighted certain practices that are widely recommended. Which of the following, however, is NOT effective in preventing the spread of COVID-19? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q4385253",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305829,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1% glutaraldehyde</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A 1% glutaraldehyde solution does not prove effective in preventing the transmission of COVID-19.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Face Mask:</strong> Wearing face masks significantly helps reduce the transmission of COVID-19 by blocking respiratory droplets.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 70% Alcohol:</strong> Alcoholic solutions, particularly those containing at least 60-70% alcohol, are effective in killing viruses on surfaces and are recommended for hand sanitation to reduce viral transmission.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hand Washing:</strong> Regular and thorough hand washing with soap and water for at least 20 seconds is one of the most effective ways to remove viruses and prevent the spread of COVID-19.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The key measures that effectively curb its spread include behaviors such as maintaining a physical distance of at least 6 feet from others, washing hands with soap and water for a duration of 20 seconds, or employing a hand sanitizer containing a minimum of 70% alcohol.</span></li><li><span style=\"font-size:12.0pt;\">Additionally, wearing a face mask in situations necessitating public outings remains crucial.</span></li></ul>",
    "correct_choice_id": 44327,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 11161,
    "choices": [
      {
        "id": 44610,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Yellow</span></span></span></p>"
      },
      {
        "id": 44611,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">White</span></span></span></p>"
      },
      {
        "id": 44612,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Black</span></span></span></p>"
      },
      {
        "id": 44613,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blue</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male patient undergoes a pacemaker replacement procedure at a tertiary care hospital. The surgeon successfully replaces the pacemaker and hands over the used device to the nursing staff for proper disposal as per biomedical waste management guidelines. According to the guidelines for biomedical waste management, in which colored bag should the used pacemaker be discarded? (INICET NOV 2020)</span></span></p>",
    "unique_key": "Q8272290",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305874,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Blue</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to biomedical waste management guidelines, used pacemakers, which are considered metal waste, should be disposed of in blue-colored containers or cardboard boxes marked with blue. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This ensures that the device is appropriately handled, disinfected, and sent for recycling or other safe disposal methods.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-092807_2cmcsm5.png\" style=\"height:824px; width:1000px\" /></p>",
    "correct_choice_id": 44613,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11139,
    "choices": [
      {
        "id": 44522,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Paired t test</span></p>"
      },
      {
        "id": 44523,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Unpaired t test</span></p>"
      },
      {
        "id": 44524,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">ANOVA</span></p>"
      },
      {
        "id": 44525,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Chi-square test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Two distinct patient cohorts at AIIMS New Delhi are subjected to different treatments to monitor their post-treatment blood pressure levels. The groups do not have overlapping members. Which statistical test would best suit the analysis of the blood pressure differences between the two groups? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q3269151",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305852,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Unpaired t test</strong></span><br>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">In the provided situation, two distinct groups are under comparison, and therefore, the appropriate statistical analysis would involve employing a Student's t-test or an unpaired t-test.</span></li><li><span style=\"color:black;font-size:12.0pt;\">T tests are used if 2 groups are being compared. If the same group is compared before and after, paired T test is used. Otherwise, unpaired T test is used.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Paired t test:</strong> Used when comparing the same group before and after an intervention, not suitable for independent groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. ANOVA:</strong> Used for comparing means among three or more groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chi-square test:</strong> Used for categorical data, not for comparing means of continuous data.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture25333.jpg\" alt=\"\" width=\"900\" height=\"485\"></p>",
    "correct_choice_id": 44523,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11162,
    "choices": [
      {
        "id": 44614,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Yellow</span></span></span></p>"
      },
      {
        "id": 44615,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Red</span></span></span></p>"
      },
      {
        "id": 44616,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blue</span></span></span></p>"
      },
      {
        "id": 44617,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transparent</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A nurse removes her latex gloves contaminated with blood and bodily fluids after a procedure. According to biomedical waste management guidelines, into which colored bag should she place the used gloves for disposal? (INICET NOV 2020)</span></span></p>",
    "unique_key": "Q2152016",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305875,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Red</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Latex gloves contaminated with blood and other bodily fluids are considered contaminated waste (recyclable) and should be disposed of in red-colored bags or containers. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This category includes items like tubing, bottles, intravenous tubes and sets, catheters, urine bags, syringes (without needles), and gloves.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-092807_eQEsiJX.png\" style=\"height:824px; width:1000px\" /></p>",
    "correct_choice_id": 44615,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 57602,
    "choices": [
      {
        "id": 229777,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thiamine</span></span></span></p>"
      },
      {
        "id": 229778,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Riboflavin</span></span></span></p>"
      },
      {
        "id": 229779,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Niacin</span></span></span></p>"
      },
      {
        "id": 229780,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cyanocobalamin</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A particular community population has been consuming Maize as a staple diet for years. The vitamin deficiency most likely to be seen in this population is:</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (NEET PG 2024)</span></span></p>",
    "unique_key": "Q2732212",
    "question_audio": null,
    "question_video": null,
    "map_id": 34306010,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Niacin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Maize, commonly consumed as a staple food in many communities, is deficient in the amino acid tryptophan, which is crucial for the synthesis of niacin (Vitamin B3) in the body. Niacin can be synthesized endogenously from tryptophan at a conversion rate of <strong>60 mg of tryptophan to 1 mg of niacin. </strong>However, when maize is a primary dietary component, the body lacks sufficient tryptophan, leading to niacin deficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Moreover, <strong>maize is high in leucine</strong>, an amino acid that inhibits the conversion of tryptophan to niacin via the kynurenine pathway. This combination of low tryptophan and high leucine content makes niacin deficiency prevalent in populations consuming maize as a staple diet, resulting in pellagra.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pellagra is characterized by the &ldquo;4 Ds&rdquo;: Diarrhea, Dermatitis, Dementia, and Death if untreated</span></strong><span style=\"font-size:12.0pt\">.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Thiamine:</span></strong><span style=\"font-size:12.0pt\"> Thiamine deficiency is typically associated with polished rice consumption, not maize. It leads to conditions like <strong>beriberi.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Riboflavin:</span></strong><span style=\"font-size:12.0pt\"> Riboflavin deficiency, though possible, is not specifically linked to maize consumption. It typically results from general dietary insufficiency of various foods, not specific to maize.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Cyanocobalamin:</span></strong><span style=\"font-size:12.0pt\"> Cyanocobalamin (Vitamin B12) deficiency is generally seen in populations with low intake of animal products and is not related to maize consumption.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Maize as a staple diet leads to niacin deficiency due to its low tryptophan and high leucine content, resulting in pellagra.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note &ndash; Leucine is known as pellagrogenic aminoacid in India</span></strong></span></span></p>",
    "correct_choice_id": 229779,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11120,
    "choices": [
      {
        "id": 44446,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nominal</span></span></span></p>"
      },
      {
        "id": 44447,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ordinal</span></span></span></p>"
      },
      {
        "id": 44448,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Qualitative</span></span></span></p>"
      },
      {
        "id": 44449,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metric</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old male with chronic liver disease is evaluated using the Child-Pugh score, which categorizes patients into classes based on disease severity. Which type of data does the Child-Pugh scoring system represent? (AIIMS NOV 2017)</span></span></p>",
    "unique_key": "Q4650328",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305830,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Ordinal</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Child-Pugh score is used to assess the severity and prognosis of chronic liver disease by categorizing patients into different classes based on specific criteria. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This score assigns patients to Class A, B, or C based on their total points, indicating varying levels of disease severity and prognosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is an ordinal scale of data.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Nominal:</span></strong><span style=\"font-size:12.0pt\"> Incorrect. Nominal data involves categories without order, which does not apply to the ordered nature of the Child-Pugh score.</span></span></span></p>\r\n\r\n<p style=\"margin-left:9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Qualitative:</span></strong><span style=\"font-size:12.0pt\"> Incorrect. While the Child-Pugh score is qualitative in describing severity, the specific classification into ordered categories makes it ordinal.</span></span></span></p>\r\n\r\n<p style=\"margin-left:9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Metric:</span></strong><span style=\"font-size:12.0pt\"> Incorrect. Metric data involves quantitative measurements with consistent intervals, which does not describe the ordinal nature of the Child-Pugh score.</span></span></span></p>\r\n\r\n<p style=\"margin-left:9px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:9px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-093615.png\" style=\"height:523px; width:1000px\" /></p>",
    "correct_choice_id": 44447,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11137,
    "choices": [
      {
        "id": 44514,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Shake test</span></p>"
      },
      {
        "id": 44515,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Schick test</span></p>"
      },
      {
        "id": 44516,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Habel test</span></p>"
      },
      {
        "id": 44517,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Tine test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">During your rural internship, you are tasked with overseeing vaccine distribution to Community Health Centres (CHCs) and Primary Health Centres (PHCs). Due to the tropical climate and frequent power outages at your posting area, ensuring the vaccines' integrity is crucial. Which of the following tests would you employ to check if the vaccines have incurred any freeze damage due to temperature fluctuations? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q8618640",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305850,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) Shake test</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"color:black;font-size:12.0pt;\">Utility: Used to check if Freeze sensitive vaccines have been damaged by exposure to freezing temperatures below 0 degrees C; After the test the previously Frozen vaccine shows flakes. Shake Test is used to assess the freeze damage to Aluminium based freeze sensitive vaccines such as DPT, TT, Td etc.&nbsp;</span></li><li><span style=\"color:black;font-size:12.0pt;\"><strong>Method of Shake test:</strong></span><ul><li><span style=\"color:black;font-size:12.0pt;\">Test Vial: Vial which is suspected to have been frozen&nbsp;</span></li><li><span style=\"color:black;font-size:12.0pt;\">Frozen control vial: Take a similar (as Test vial) vaccine vial with same manufacturer, batch number, antigen(s), Label it properly. Freeze it overnight at -20 degrees C, then let it haw (Do not heat)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Hold the Test vial and Control vials between thumb and forefinger and shake them vigorously (10-15 seconds)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Place both vials on even flat surface for 30 minutes observation, compare the sedimentation rates (SR). If the sediments in the suspect vial settle more slowly, the suspect vaccine may be used.</span></li></ul></li><li><span style=\"color:black;font-size:12.0pt;\">Interpretation:</span><ul><li><span style=\"color:black;font-size:12.0pt;\">If SR in Test vial &lt; Control vial: Vaccine had not been damaged</span></li><li><span style=\"color:black;font-size:12.0pt;\">If SR in Test vial &gt; Control vial: Vaccine had been damaged,</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Do not use and Inform the supervisors</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture23555.jpg\" alt=\"\" width=\"500\" height=\"491\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Schick test:</strong> This is a skin test for susceptibility to diphtheria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Habel test:</strong> This is used to measure the potency of rabies vaccines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tine test:</strong> This is a skin test for tuberculosis.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>The Shake Test currently applies to freeze sensitive vaccines which are:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">DPT-Hep B-Hib</span></li><li><span style=\"color:black;font-size:12.0pt;\">TT</span></li><li><span style=\"color:black;font-size:12.0pt;\">PCV13</span></li><li><span style=\"color:black;font-size:12.0pt;\">Hepatitis B</span></li><li><span style=\"color:black;font-size:12.0pt;\">HPV</span></li></ul>",
    "correct_choice_id": 44514,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11171,
    "choices": [
      {
        "id": 44650,
        "text": "<p><span style=\"font-size:12.0pt;\">VMV</span></p>"
      },
      {
        "id": 44651,
        "text": "<p><span style=\"font-size:12.0pt;\">VVM</span></p>"
      },
      {
        "id": 44652,
        "text": "<p><span style=\"font-size:12.0pt;\">MVV</span></p>"
      },
      {
        "id": 44653,
        "text": "<p><span style=\"font-size:12.0pt;\">IVMI</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A public health officer is reviewing the storage conditions of various vaccines in a rural health center. She wants to ensure that all the vaccines have been stored appropriately and have not been exposed to temperatures outside the recommended range. She is looking for a specific indicator on the vaccine vials that shows the cumulative heat exposure over time. Which of the following is the correct indicator she should check? (INICET NOV 2020)</span></p>",
    "unique_key": "Q8788364",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305884,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) VVM</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Vaccine vial monitors (VVM) are heat-sensitive indicators routinely used to monitor heat exposure of the vaccine and determine vaccine viability as the vaccine vial moves across the supply chain.</span></li><li><span style=\"font-size:12.0pt;\">VVMs change color as the vaccine is exposed to cumulative heat. If the color of inner square is similar or darker than the outer circle, the vaccine vial should be discarded.</span></li><li><span style=\"font-size:12.0pt;\">A VVM can be used to assess vaccine potency and not vaccine efficacy.</span></li><li><span style=\"font-size:12.0pt;\">Expiry date can\u2019t be determined by VVM and has no relation to extend the expiry date.</span></li><li><span style=\"font-size:12.0pt;\">If the square and the circle are the same in color, then the vaccine should be discarded.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/30/picture52222.jpg\" alt=\"\" width=\"500\" height=\"264\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Vaccine Vial Monitor (VVM) as the correct tool used to indicate the cumulative heat exposure of vaccines over time, ensuring their potency and safe use.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/30/screenshot-2023-10-27-130342.jpg\" alt=\"\" width=\"700\" height=\"500\"></span></p>",
    "correct_choice_id": 44651,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11156,
    "choices": [
      {
        "id": 44590,
        "text": "<p><span style=\"font-size:12.0pt;\">2 drug therapy for 6 months</span></p>"
      },
      {
        "id": 44591,
        "text": "<p><span style=\"font-size:12.0pt;\">3 drug therapy for 12 months</span></p>"
      },
      {
        "id": 44592,
        "text": "<p><span style=\"font-size:12.0pt;\">2 drug therapy for 12 months</span></p>"
      },
      {
        "id": 44593,
        "text": "<p><span style=\"font-size:12.0pt;\">3 drug therapy for 6 months</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old man presents with 2-3 hypopigmented, slightly raised patches on his forearm with reduced sensation for 4 months. He is diagnosed with paucibacillary leprosy. What is the recommended treatment regimen? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q8805319",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305869,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 2 drug therapy for 6 months</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The treatment regimen for paucibacillary leprosy involves a 6-month course of drug therapy with 2 drugs (Dapsone, Rifampicin).</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis of leprosy under NLEP: It is currently based on clinical grounds (revised case definition) -&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Paucibacillary (PB) case</strong>: A case of leprosy with 1 to 5 skin lesions, without demonstrated presence of bacilli in a skin smear;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Multibacillary (MB) case</strong>: A case of leprosy with more than five skin lesions; or with&nbsp;nerve involvement (pure neuritis, or any number of skin lesions and neuritis); or with the demonstrated presence of bacilli in a slit-skin smear, irrespective of the number of skin lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-174718.jpg\" alt=\"\" width=\"800\" height=\"251\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/33333.jpg\" alt=\"\" width=\"250\" height=\"250\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>MDT blister pack Colour</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PBL adult - Green color</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MBL adult - Red color</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PBL child - Blue color</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MBL child - Yellow colour&nbsp;</span></p>",
    "correct_choice_id": 44590,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 11157,
    "choices": [
      {
        "id": 44594,
        "text": "<p><span style=\"font-size:12.0pt;\">Kyasanur forest disease virus</span></p>"
      },
      {
        "id": 44595,
        "text": "<p><span style=\"font-size:12.0pt;\">Orientia tsutsugamushi</span></p>"
      },
      {
        "id": 44596,
        "text": "<p><span style=\"font-size:12.0pt;\">Chandipura virus</span></p>"
      },
      {
        "id": 44597,
        "text": "<p><span style=\"font-size:12.0pt;\">Anaplasma phagocytophilia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with flu-like symptoms after a camping trip and multiple insect bites. You suspect a vector-borne illness. Which pathogen is likely if the vector is a Trombiculid mite? (AIIMS NOV 2019)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip42.jpg\" alt=\"\" width=\"300\" height=\"278\"></p>",
    "unique_key": "Q6533170",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305870,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Orientia tsutsugamushi</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Above given image depicts Trombiculid mite, which transmits Orientia tsutsugamushi. It causes scrub typhus disease in humans.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture5666.jpg\" alt=\"\" width=\"600\" height=\"663\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Life cycle of Trombiculid mite with transovarial transmission</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Kyasanur forest disease virus:</strong> Kyasanur forest disease virus is transmitted by hard tick</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/image.png\" width=\"283\" height=\"292\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chandipura virus:&nbsp;</strong>Chandipura virus is an Arbovirus transmitted by Sand fly (Phlebotomus)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture7666.jpg\" alt=\"\" width=\"300\" height=\"284\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Anaplasma phagocytophilia:&nbsp;</strong>Anaplasma phagocytophilia (formerly Ehrlichia phagocytophilum) is a Gram-negative bacterium that causes an acute febrile illness known as anaplasmosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Orientia tsutsugamushi, transmitted by Trombiculid mites, causes scrub typhus.</span></li></ul>",
    "correct_choice_id": 44595,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 11150,
    "choices": [
      {
        "id": 44566,
        "text": "<p><span style=\"font-size:12.0pt;\">Low volume, high calories</span></p>"
      },
      {
        "id": 44567,
        "text": "<p><span style=\"font-size:12.0pt;\">High volume, low calories</span></p>"
      },
      {
        "id": 44568,
        "text": "<p><span style=\"font-size:12.0pt;\">High volume, high calories</span></p>"
      },
      {
        "id": 44569,
        "text": "<p><span style=\"font-size:12.0pt;\">Low volume, low calories</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old male with a history of hypertension and diabetes, recently diagnosed with end-stage renal disease (stage 5) and on hemodialysis, seeks dietary advice. Which of the following characterizes the ideal renal feed for him? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q1533522",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305863,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Low volume, high calories</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">An ideal diet for a patient with end-stage renal disease should consist of low volume but high calorie intake. The patient's dietary choices can significantly impact the advancement of kidney disease and its associated complications. Opting for a diet that is low in volume is recommended to prevent:</span><ul><li><span style=\"font-size:12.0pt;\">Sodium and volume overload</span></li><li><span style=\"font-size:12.0pt;\">Hyperkalemia</span></li><li><span style=\"font-size:12.0pt;\">Hyperphosphatemia</span></li><li><span style=\"font-size:12.0pt;\">Accumulation of toxic metabolites of protein degradation</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Opting for a high-calorie diet is recommended for the potential malnutrition and wasting risks observed in individuals with End-Stage Renal Disease (ESRD).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. High volume, low calories:&nbsp;</strong>This could lead to volume overload and insufficient caloric intake.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. High volume, high calories:&nbsp;</strong>High volume can cause fluid overload issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Low volume, low calories:&nbsp;</strong>Insufficient calories can exacerbate malnutrition and wasting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">An ideal diet for patients with end-stage renal disease should be low in volume to manage fluid balance and high in calories to prevent malnutrition and wasting.</span></li></ul>",
    "correct_choice_id": 44566,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 11155,
    "choices": [
      {
        "id": 44586,
        "text": "<p><span style=\"font-size:12.0pt;\">Meningitis prophylaxis in exposed contacts/relatives</span></p>"
      },
      {
        "id": 44587,
        "text": "<p><span style=\"font-size:12.0pt;\">Hand washing</span></p>"
      },
      {
        "id": 44588,
        "text": "<p><span style=\"font-size:12.0pt;\">Vaccination</span></p>"
      },
      {
        "id": 44589,
        "text": "<p><span style=\"font-size:12.0pt;\">Adding iron to wheat flour</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old public health nurse is attending a seminar on primary prevention strategies. She needs to identify interventions that fall under specific protection, a subset of primary prevention. Which of the following interventions does NOT come under the primary level of prevention for specific protection? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q9037802",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305868,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hand washing</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Specific protection mode of disease prevention: Is a Primary level of disease prevention (applied when risk factors are present in environment but disease has not yet taken place).</span></li><li><span style=\"font-size:12.0pt;\">Risk factors are already present but disease is prevented from occurring by using a specific modality. Ex - Vaccines &amp; Vit A supplementation under NIS, chemoprophylaxis, IFA supplementation, contraception, ITN, etc</span></li><li><span style=\"font-size:12.0pt;\">Handwashing fall within the category of primary prevention as a Health Promotion measure, not specific protection, as it is not a protective measures targeted at any particular disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Meningitis prophylaxis in exposed contacts/relatives:&nbsp;</strong>This is a form of specific protection, aimed at preventing the onset of meningitis in those exposed to the infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vaccination:&nbsp;</strong>Vaccination is a classic example of specific protection, preventing the occurrence of specific diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Adding iron to wheat flour:&nbsp;</strong>This is a specific protection measure to prevent iron deficiency anemia in the population by fortifying commonly consumed food products.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Hand washing is a health promotion measure and does not fall under specific protection in primary prevention strategies.</span></li><li><span style=\"font-size:12.0pt;\">Note - Chinese Medicine is the Pioneer in concept of \u2018Specific protection by vaccine\u2019</span></li></ul>",
    "correct_choice_id": 44587,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11143,
    "choices": [
      {
        "id": 44538,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">6 drugs for 4-6 months followed by 4 drugs for 12 months</span></p>"
      },
      {
        "id": 44539,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">7 drugs for 4-6 months followed by 4 drugs for 5 months</span></p>"
      },
      {
        "id": 44540,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">4 drugs for 4 months followed by 6 drugs for 10-12 months</span></p>"
      },
      {
        "id": 44541,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">5 drugs for 6 months followed by 4 drugs for 12 months</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient is diagnosed with multi-drug resistant tuberculosis (MDR-TB). According to the World Health Organization's guidelines, which of the following treatment schedules is recommended? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q8309377",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305856,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) 7 drugs for 4-6 months followed by 4 drugs for 5 months</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">WHO defines Multi-drug resistant (MDR) Tuberculosis strain as Resistant to INH and Rifampicin with or without resistant to other anti TB drugs</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Treatment of MDR-TB:</span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\"><strong>DOTS PLUS (Older name: Category IV)</strong></span></li><li><span style=\"color:black;font-size:12.0pt;\">Must be done on basis of sensitivity testing</span></li><li><span style=\"color:black;font-size:12.0pt;\">Directly observed therapy certainly helps to improve outcomes and is considered an integral part of MDR-TB treatment</span><ul><li><span style=\"color:black;font-size:12.0pt;\">The recommended treatment regimen for multi-drug resistant tuberculosis (MDR-TB) involves a two-phase approach.</span></li><li><span style=\"font-size:12.0pt;\">In the initial phase, patients are prescribed a combination of seven drugs for a duration of 4 to 6 months. These seven drugs are collectively referred to as CHOBZEE, which stands for Clofazimine, High dose Isoniazid, Levofloxacin, Bedaquiline, Pyrazinamide, Ethambutol, and Ethionamide.</span></li><li><span style=\"font-size:12.0pt;\">Following the initial phase, the treatment enters a second phase where four drugs are continued for an additional 5 months. These four drugs are collectively known as COZE, consisting of Clofazimine, Levofloxacin, Pyrazinamide, and Ethambutol. Note: Bedaquiline is always given for 6 months.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>New Regimens for Treatment Drug Resistant TB (RNTCP 2017-18)</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-120911.png\" alt=\"\" width=\"1000\" height=\"408\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">(Drugs: Hh: High dose isoniazid; E:Ethambutol; Z:Pyrazinamide; K:Kanamycin; Cm: Capreomycin; A Amikacin; L: Levofloxacin; M: Moxifloxacin; Mh: High dose moxifloxacin; Et; Ethionamide; Cs: Cycloserine; Cz: Clofazimine; Lz: Linezolid; Bq: Bedaquiline</span></p>",
    "correct_choice_id": 44539,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 57600,
    "choices": [
      {
        "id": 229769,
        "text": "<p><span style=\"font-size:12.0pt;\">Crude birth rate \u2013 Crude death rate</span></p>"
      },
      {
        "id": 229770,
        "text": "<p><span style=\"font-size:12.0pt;\">Crude birth rate + Crude death rate</span></p>"
      },
      {
        "id": 229771,
        "text": "<p><span style=\"font-size:12.0pt;\">Crude birth rate / Crude death rate</span></p>"
      },
      {
        "id": 229772,
        "text": "<p><span style=\"font-size:12.0pt;\">Crude birth rate \u00d7 Crude death rate</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is Demographic gap? (NEET PG 2024)</span></p>",
    "unique_key": "Q6989351",
    "question_audio": null,
    "question_video": null,
    "map_id": 34306012,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Crude birth rate \u2013 Crude death rate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The demographic gap refers to the difference between the crude birth rate and the crude death rate. It essentially measures the net increase in the population, referred to as the <strong>growth rate.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In demographic terms:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A positive demographic gap indicates that the birth rate is higher than the death rate, leading to population growth.</span></li><li><span style=\"font-size:12.0pt;\">A negative demographic gap indicates a declining population when the death rate exceeds the birth rate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The demographic gap is minimal during the early and late stages of the demographic transition model (Stages 1 and 4), where birth and death rates are balanced or declining. It peaks during Stage 2 when the birth rate remains high but the death rate drops significantly. In Stage 3, the gap starts to contract as birth rates begin to fall, and in Stage 5, it can become negative as populations age and birth rates fall below death rates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The demographic gap is defined as the difference between the crude birth rate and the crude death rate, representing the population growth rate</span></p>",
    "correct_choice_id": 229769,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 11123,
    "choices": [
      {
        "id": 44458,
        "text": "<p><span style=\"font-size:12.0pt;\">RRR 11%, ARR 11%</span></p>"
      },
      {
        "id": 44459,
        "text": "<p><span style=\"font-size:12.0pt;\">RRR 11%, ARR 1%</span></p>"
      },
      {
        "id": 44460,
        "text": "<p><span style=\"font-size:12.0pt;\">RRR 1%, ARR 11%</span></p>"
      },
      {
        "id": 44461,
        "text": "<p><span style=\"font-size:12.0pt;\">RRR 1%, ARR 1%</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A pharmaceutical company conducted a double-blind clinical trial comparing a new antidiabetic drug to a placebo. The study enrolled an equal number of participants in both arms. Based on the data below, what are the Relative Risk Reduction (RRR) and Absolute Risk Reduction (ARR) for adverse effects? (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/screenshot-2023-10-18-185941.jpg\" alt=\"\" width=\"1000\" height=\"167\"></span></p>",
    "unique_key": "Q5066772",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305833,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) RRR 11%, ARR 1%</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Calculation -</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Relative risk reduction (RRR): Percentage reduction in one outcome (E.g. Death or Adverse outcome) comparing one group (New drug) with another group (Older drug or Placebo)</span></li><li><span style=\"font-size:12.0pt;\">Absolute risk reduction (ARR): Reduction in outcome (E.g. Death or Adverse outcome) comparing one group (New drug) with another group (Older drug or Placebo)</span></li><li><span style=\"font-size:12.0pt;\">Event is taken as Occurrence of adverse outcome in the given example</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the given question,</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Event rate Drug = 1603/15225 \u00d7 100 = 10.5% (0.105)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Event rate Placebo = 1804/15225 \u00d7 100 = 11.8% (0.118)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hence,</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Relative risk of Event rate = Event rate drug/Event rate Placebo = 0.105/0.118 = 0.9</span></li><li><span style=\"font-size:12.0pt;\">Relative risk reduction (RRR) = (Event rate Placebo \u2013 Event rate drug)/Event rate placebo = (0.118)\u20130.105)/0.118 = 0.11 = 11%</span></li><li><span style=\"font-size:12.0pt;\">Absolute risk reduction = Event rate Drug \u2013 Event rate Placebo = 0.105 \u2013 0.118 = \u2013 0.013 = \u2013 1.3%</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Relative Risk Reduction (RRR) reflects the proportionate reduction in risk between two groups, while the Absolute Risk Reduction (ARR) provides the difference in risk between them</span></p>",
    "correct_choice_id": 44459,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 57606,
    "choices": [
      {
        "id": 229793,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">BCG</span></span></span></p>"
      },
      {
        "id": 229794,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">OPV</span></span></span></p>"
      },
      {
        "id": 229795,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">DPT</span></span></span></p>"
      },
      {
        "id": 229796,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rotaviral vaccine</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vaccine kept at the lowest level inside an Ice lined refrigerator (ILR) at PHC: (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q7841340",
    "question_audio": null,
    "question_video": null,
    "map_id": 34306006,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp; </span></strong><strong><span style=\"font-size:12.0pt\">B) OPV</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In an Ice Lined Refrigerator (ILR), which is commonly used at Primary Health Centers (PHCs) to store vaccines, the temperature varies from 2&deg;C at the bottom to 8&deg;C at the top. Vaccines that require colder temperatures, closer to 2&deg;C, are stored at the lowest level of the refrigerator because cold air settles down.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">OPV (Oral Polio Vaccine)</span></strong><span style=\"font-size:12.0pt\">: OPV is stored at the lowest level of the ILR because it requires a colder environment. It can even tolerate freezing temperatures and can be stored in a deep freezer at -15&deg;C to -25&deg;C, making it suitable for the coldest section of the refrigerator.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Lyophilized vaccines</span></strong><span style=\"font-size:12.0pt\"> like BCG, measles, and rotaviral vaccine are also stored at lower levels since they need a stable and colder temperature.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174639.jpg\" style=\"height:397px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. BCG:</span></strong><span style=\"font-size:12.0pt\"> While BCG is a lyophilized vaccine and is stored at a lower level, it is not specifically the answer for this question as OPV is more specifically associated with the lowest level due to its freezing tolerance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. DPT:</span></strong><span style=\"font-size:12.0pt\"> DPT vaccine is stored at the upper levels of the ILR where temperatures are closer to 6-8&deg;C. This vaccine does not require the colder conditions found at the bottom of the refrigerator.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Rotaviral vaccine:</span></strong><span style=\"font-size:12.0pt\"> Similar to BCG, the rotaviral vaccine is a lyophilized vaccine stored lower in the ILR, but OPV is the more critical vaccine stored at the lowest level due to its requirement for cold and even freezing conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">OPV is stored at the lowest level of the ILR due to its requirement for the coldest storage conditions, ranging from 2&deg;C and even tolerating freezing conditions, ensuring vaccine potency and effectiveness.</span></span></p>",
    "correct_choice_id": 229794,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 11169,
    "choices": [
      {
        "id": 44642,
        "text": "<p><span style=\"font-size:12.0pt;\">Binomial distribution</span></p>"
      },
      {
        "id": 44643,
        "text": "<p><span style=\"font-size:12.0pt;\">Gaussian distribution</span></p>"
      },
      {
        "id": 44644,
        "text": "<p><span style=\"font-size:12.0pt;\">Poisson distribution</span></p>"
      },
      {
        "id": 44645,
        "text": "<p><span style=\"font-size:12.0pt;\">Normal distribution</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A clinician is conducting a study on the occurrence of a rare disease within a specific population over a certain time period. The disease cases occur independently, and the average rate of occurrence is constant. Which statistical distribution best represents the likelihood of observing a specific number of disease cases within this defined time period? (INICET NOV 2020)</span></p>",
    "unique_key": "Q7297895",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305882,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Poisson distribution</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Poisson Distribution</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is a \u2018discrete probability distribution\u2019 that expresses the \u2018probability of a number of events occurring in a fixed period of time\u2019 (if these events occur with a known average rate and independently of the time since the last event).</span></li><li><span style=\"font-size:12.0pt;\">It can also be used for the number of events in other specified intervals such as distance, area or volume.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Binomial distribution</strong> is used for those events which can only have two possible results given as yes or no / success or failure. It is usually done for finite number of events unlike Poisson\u2019s distribution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Gaussian distribution/ D. Normal distribution</strong> is the distribution of values of a quantitative variable such that they are symmetric with respect to a middle value with same mean, median and mode, and then the frequencies taper off rapidly and symmetrically on both sides \u2013 \u2018bell shaped distribution\u2019.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The Poisson distribution is used to model the number of rare disease cases occurring independently in a fixed period of time.</span></li></ul>",
    "correct_choice_id": 44644,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11086,
    "choices": [
      {
        "id": 44310,
        "text": "<p><span style=\"font-size:12.0pt;\">Polysaccharide vaccine</span></p>"
      },
      {
        "id": 44311,
        "text": "<p><span style=\"font-size:12.0pt;\">Toxoid</span></p>"
      },
      {
        "id": 44312,
        "text": "<p><span style=\"font-size:12.0pt;\">Killed vaccine</span></p>"
      },
      {
        "id": 44313,
        "text": "<p><span style=\"font-size:12.0pt;\">Live attenuated vaccine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A healthcare professional is reviewing vaccine protocols to update patient information materials. In doing so, she focuses on the type of vaccine used for diphtheria prevention. Which option correctly describes the type of diphtheria vaccine? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q2354757",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305825,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Toxoid</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The diphtheria vaccine is a <strong>toxoid vaccine</strong>, which involves the use of toxins produced by the bacterium that causes the disease.</span></li><li><span style=\"font-size:12.0pt;\">These toxins are chemically inactivated to form toxoids, which are safe for use in vaccines but still capable of eliciting a strong immune response.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Types of vaccine -&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-145824.png\" alt=\"\" width=\"1000\" height=\"534\"></p>",
    "correct_choice_id": 44311,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11136,
    "choices": [
      {
        "id": 44510,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1/2 protein and 1/3 calorie requirements</span></p>"
      },
      {
        "id": 44511,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1/3 protein and 1/3 calorie requirements</span></p>"
      },
      {
        "id": 44512,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1/2 protein and 1/2 calorie requirements</span></p>"
      },
      {
        "id": 44513,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1/3 protein and 1/2 calorie requirements</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following best describes the nutritional targets of Mid-Day Meal Program,</span><span style=\"color:black;font-size:12.0pt;\"> as per the Indian government guidelines? </span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2018)</span></p>",
    "unique_key": "Q3890930",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305849,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) 1/2 protein and 1/3 calorie requirements</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">The meal should supplement 1/3 of the total energy requirement and 1/2 of the total protein requirement.</span></li><li><span style=\"color:black;font-size:12.0pt;\"><strong>Mid-day meal programme (MDMP):</strong> Also known as \u2018School Lunch Programme\u2019, it has been in operation since 1961.</span><ul style=\"list-style-type:circle;\"><li><span style=\"color:black;font-size:12.0pt;\">The <strong>major objective</strong> of MDMP: To attract more children for admission to schools and retain them so that literacy improvement of children could be brought about.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The meal is a supplement and not a substitute to the home diet</span></li><li><span style=\"color:black;font-size:12.0pt;\">The meal should supply 1/3 of the total energy requirement and 1/2 of the total protein requirement</span></li><li><span style=\"color:black;font-size:12.0pt;\">MDMP is being operationalised under the Ministry of Human Resource &amp; Development&nbsp;</span></li><li><span style=\"color:black;font-size:12.0pt;\">National Institute of Nutrition, Hyderabad is of the view that minimum number of feeding days in year be 250 to have the desired impact on children</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Mid-day meal scheme (MDMS) (National Programme of Nutritional Support to Primary Education):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Launched in 1995</span></li><li><span style=\"color:black;font-size:12.0pt;\">Main objective: Universalisation of primary education by increasing enrolment, retention and attendance and simultaneously impacting on nutrition of students in primary classes</span></li><li><span style=\"color:black;font-size:12.0pt;\">The mid-day meal should supply 1/3 of the total energy requirement and 1/2 of the total protein requirement</span></li><li><span style=\"color:black;font-size:12.0pt;\">A model menu for mid-day school meal -</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture22333.jpg\" alt=\"\" width=\"700\" height=\"422\"></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Principles for formulating mid-day meals:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Meal should be a supplement only not a substitute for home diet</span></li><li><span style=\"color:black;font-size:12.0pt;\">Meal should provide 1/3 calories and 1/2 proteins</span></li><li><span style=\"color:black;font-size:12.0pt;\">Meal cost should be low</span></li><li><span style=\"color:black;font-size:12.0pt;\">Complicated cooking process must not be involved</span></li><li><span style=\"color:black;font-size:12.0pt;\">Use locally available foods</span></li><li><span style=\"color:black;font-size:12.0pt;\">Keep changing menu frequently</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Mid-Day Meal Scheme is now renamed as PM POSHAN or Pradhan Mantri Poshan Shakti Nirman.</strong></span></p>",
    "correct_choice_id": 44510,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11134,
    "choices": [
      {
        "id": 44502,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">TB</span></p>"
      },
      {
        "id": 44503,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Leprosy</span></p>"
      },
      {
        "id": 44504,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Vaginal discharge</span></p>"
      },
      {
        "id": 44505,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Gonorrhea</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In the infectious disease ward, you notice a multi-drug therapy packet placed neatly on a patient's bedside table. Based on the drug composition, which of the following diseases do you think the packet is intended to treat? (AIIMS NOV 2018)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture1533.jpg\" alt=\"\" width=\"300\" height=\"351\"></span></p>",
    "unique_key": "Q8715055",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305847,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Leprosy</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">The given image shows the adult blister packet used in the treatment of leprosy.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture1633.jpg\" alt=\"\" width=\"700\" height=\"497\"></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture17333.jpg\" alt=\"\" width=\"700\" height=\"512\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture1866.jpg\" alt=\"\" width=\"700\" height=\"505\"></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture1933.jpg\" alt=\"\" width=\"700\" height=\"523\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. TB:</strong> TB treatment involves a different combination of drugs, typically including isoniazid, rifampicin, pyrazinamide, and ethambutol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vaginal discharge:</strong> Treatment for vaginal discharge depends on the specific cause, such as bacterial, fungal, or protozoal infection, and usually involves single-agent therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Gonorrhea:</strong> Gonorrhea treatment generally involves antibiotics like ceftriaxone and azithromycin, not a multi-drug blister packet.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Multi-drug therapy packets containing drugs like rifampicin, clofazimine, and dapsone are specifically intended for the treatment of leprosy.</span></li></ul>",
    "correct_choice_id": 44503,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 11153,
    "choices": [
      {
        "id": 44578,
        "text": "<p><span style=\"font-size:12.0pt;\">No treatment</span></p>"
      },
      {
        "id": 44579,
        "text": "<p><span style=\"font-size:12.0pt;\">2 doses of vaccine on Day 0 &amp; 3</span></p>"
      },
      {
        "id": 44580,
        "text": "<p><span style=\"font-size:12.0pt;\">5 doses of vaccine with Immunoglobulin</span></p>"
      },
      {
        "id": 44581,
        "text": "<p><span style=\"font-size:12.0pt;\">5 doses of vaccine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old boy, previously vaccinated against rabies a year ago, was bitten by his vaccinated family pet dog on the toe, resulting in a bleeding wound. What is the most appropriate next step in the management of this child? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q5225387",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305866,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2 doses of vaccine on Day 0 &amp; 3</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The patient should receive 2 doses of vaccine on days 0 &amp; 3 as he has already received a prior course of post-exposure prophylaxis (PEP) &gt; 3 months ago.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-174245.jpg\" alt=\"\" width=\"1000\" height=\"512\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">For a previously vaccinated individual bitten by a potentially rabid animal, the appropriate post-exposure prophylaxis is to administer 2 booster doses of the rabies vaccine on days 0 and 3.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-174320.jpg\" alt=\"\" width=\"1000\" height=\"442\"></span></p>",
    "correct_choice_id": 44579,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 11127,
    "choices": [
      {
        "id": 44474,
        "text": "<p><span style=\"font-size:12.0pt;\">Give IV antibiotics and observe</span></p>"
      },
      {
        "id": 44475,
        "text": "<p><span style=\"font-size:12.0pt;\">Give IV antibiotics and refer to higher centre</span></p>"
      },
      {
        "id": 44476,
        "text": "<p><span style=\"font-size:12.0pt;\">Oral antibiotics, warn of danger signs, and send home</span></p>"
      },
      {
        "id": 44477,
        "text": "<p><span style=\"font-size:12.0pt;\">No need of treatment only home remedies</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A pediatrician at a district hospital encounters an 18-month-old boy from a remote village with breathing difficulties, cough, cold, and fever for the past few days. The child is active, with a respiratory rate of 46 breaths per minute and no chest retractions. How should the pediatrician advise the parents? (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q2292945",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305837,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Oral antibiotics, warn of danger signs, and send home</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Based on the provided clinical information, it is evident that the child is suffering from pneumonia.</span></li><li><span style=\"font-size:12.0pt;\">The recommended treatment for pneumonia in children aged 2 months to 5 years involves administering oral amoxicillin along with home care.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/22222.jpg\" alt=\"\" width=\"700\" height=\"302\"></span></p>",
    "correct_choice_id": 44476,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 11131,
    "choices": [
      {
        "id": 44490,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Adult Japanese encephalitis</span></span></span></span></p>"
      },
      {
        "id": 44491,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Influenza</span></span></span></span></p>"
      },
      {
        "id": 44492,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Measles-Rubella</span></span></span></span></p>"
      },
      {
        "id": 44493,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Rotavirus</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">As a young pediatrician practicing in India, you attend various workshops and training sessions to keep yourself updated with the latest guidelines in child health. During one such session focused on India&#39;s National Immunization Program, you discuss with your colleagues about the range of vaccines included in the program. </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following vaccines is NOT currently part of India&#39;s National Immunization Program? (AIIMS NOV 2018)</span></span></p>",
    "unique_key": "Q4904821",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305844,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. B) Influenza</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The Influenza vaccine (commonly known as the Flu shot) has not yet been included in India&#39;s National Immunization Programme.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">It&#39;s important to note that the Bacterial Hemophilus influenzae type-b (Hib) vaccine is distinct from the viral Influenza (Flu) vaccine. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The HiB vaccine is included as part of the pentavalent vaccine (DPT + HiB + HepB).</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">NEW National Immunization Schedule (NIS) 2023-24</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-113044.png\" style=\"height:493px; width:1000px\" /></span></strong></span></span></p>",
    "correct_choice_id": 44491,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 57603,
    "choices": [
      {
        "id": 229781,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Silicosis</span></span></span></p>"
      },
      {
        "id": 229782,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Byssinosis</span></span></span></p>"
      },
      {
        "id": 229783,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bagassosis</span></span></span></p>"
      },
      {
        "id": 229784,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lead poisoning</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A person reported to OPD alongside his 32-year-old brother working in a factory. The brother was recently subjected to a test &ndash; Coproporphyrin in urine. The physician should suspect: (NEET PG 2024)</span></span></p>",
    "unique_key": "Q3869289",
    "question_audio": null,
    "question_video": null,
    "map_id": 34306009,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">D) Lead poisoning</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of coproporphyrin in urine is commonly associated with lead exposure, making it an important <strong>screening test for lead poisoning</strong>. Coproporphyrin in urine indicates exposure to lead, but it does not confirm whether significant absorption has occurred. To determine absorption, a specific diagnostic test called Aminolevulinic Acid in Urine (ALAU) is used. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CPU &ndash; screening test &ndash; indicates lead Exposure - &gt;150 mcg/L</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ALAU &ndash; diagnostic test &ndash; indicated lead absorption - &gt; 5mg/L</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Elevated levels of lead in urine (&gt;800 &micro;g/L) signify both exposure and absorption, while levels above 700 &micro;g/L indicate the onset of clinical symptoms. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lead poisoning, also known as plumbism, is treated with chelation therapy using EDTA combined with dimercaprol, which helps remove lead from the body.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Silicosis: </span></strong><span style=\"font-size:12.0pt\">Silicosis is a lung disease caused by inhaling silica dust, common in mining, quarrying, and glass manufacturing industries. It does not involve testing for coproporphyrin in urine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Byssinosis: </span></strong><span style=\"font-size:12.0pt\">Byssinosis, also known as &ldquo;brown lung disease,&rdquo; is caused by inhaling cotton, flax, or hemp dust, mainly affecting textile workers. It is unrelated to coproporphyrin levels in urine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Bagassosis: </span></strong><span style=\"font-size:12.0pt\">Bagassosis is an occupational lung disease caused by inhaling dust from bagasse, the fibrous residue of sugarcane. This condition is not associated with lead exposure or coproporphyrin levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Coproporphyrin in urine is an important screening test for lead poisoning, indicating exposure to lead, and should be followed by diagnostic tests to assess absorption.</span></span></span></p>",
    "correct_choice_id": 229784,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11126,
    "choices": [
      {
        "id": 44470,
        "text": "<p><span style=\"font-size:12.0pt;\">Students t test</span></p>"
      },
      {
        "id": 44471,
        "text": "<p><span style=\"font-size:12.0pt;\">Paired t test</span></p>"
      },
      {
        "id": 44472,
        "text": "<p><span style=\"font-size:12.0pt;\">ANOVA</span></p>"
      },
      {
        "id": 44473,
        "text": "<p><span style=\"font-size:12.0pt;\">Chi square test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A study on postpartum depression in mothers compares depression rates based on the gender of their newborns using the Edinburgh Depression Scale Score (EDSS). Which statistical method should be used to determine if there's a significant association between the newborn's gender and postpartum depression? (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q8579740",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305836,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Chi square test</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The Chi-square test serves the purpose of comparing qualitative data and involves the comparison of two groups with independent measurements.</span></li><li><span style=\"font-size:12.0pt;\">Therefore, it is the most suitable test for this context</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Students t test:&nbsp;</strong>Used for comparing means of two independent groups; not suitable for categorical data.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Paired t test:&nbsp;</strong>Used for comparing means of related groups; not suitable for independent categorical data.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. ANOVA:&nbsp;</strong>Used for comparing means of three or more groups; not suitable for categorical data with only two groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/2222.jpg\" alt=\"\" width=\"700\" height=\"376\"></span></p>",
    "correct_choice_id": 44473,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11170,
    "choices": [
      {
        "id": 44646,
        "text": "<p><span style=\"font-size:12.0pt;\">Variance</span></p>"
      },
      {
        "id": 44647,
        "text": "<p><span style=\"font-size:12.0pt;\">Coefficient of variation</span></p>"
      },
      {
        "id": 44648,
        "text": "<p><span style=\"font-size:12.0pt;\">Range</span></p>"
      },
      {
        "id": 44649,
        "text": "<p><span style=\"font-size:12.0pt;\">Interquartile range</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A statistician is examining the scores of a recent standardized test to assess the variability in student performance. She is particularly interested in understanding the extent of score dispersion from the lowest to the highest mark achieved. Which statistical measure should she use to directly determine this? (INICET NOV 2020)</span></p>",
    "unique_key": "Q2664721",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305883,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Range</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Range is expressed as minimum - maximum (or maximum \u2013 minimum) values in a given set of data.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Variance:</strong> It is given as square of standard deviation (Deviation of each value from the standard value).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Coefficient of variation (COV):</strong> It is a measure used to compare relative variability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Interquartile range:</strong> Quartiles divide the distribution into 4 equal groups. The difference between Q1 and Q3 gives the interquartile range.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-094311.png\" alt=\"\" width=\"500\" height=\"261\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The range directly measures the extent of score dispersion from the lowest to the highest value in a dataset.</span></li></ul>",
    "correct_choice_id": 44648,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11164,
    "choices": [
      {
        "id": 44622,
        "text": "<p><span style=\"font-size:12.0pt;\">Nominal scale data</span></p>"
      },
      {
        "id": 44623,
        "text": "<p><span style=\"font-size:12.0pt;\">Ordinal scale data</span></p>"
      },
      {
        "id": 44624,
        "text": "<p><span style=\"font-size:12.0pt;\">Alphanumerical data</span></p>"
      },
      {
        "id": 44625,
        "text": "<p><span style=\"font-size:12.0pt;\">Interval scale data</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A resident in neurology is assessing a patient who recently sustained a traumatic brain injury using the Glasgow Coma Scale (GCS). How should the resident describe the type of data obtained from the GCS? (INICET NOV 2020)</span></p>",
    "unique_key": "Q7336259",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305877,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ordinal scale data</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The Glasgow Coma Scale represents ordinal data since the GCS score is categorized as mild, moderate, or severe, following a specific order of severity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Nominal scale data:</strong> Data based on names without a specific order.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Alphanumerical data:</strong> Data that includes both letters and numbers, not applicable here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Interval scale data:</strong> Data measured along a scale where each point is equidistant from the next, but GCS does not meet this criterion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/30/screenshot-2023-10-30-114041.jpg\" alt=\"\" width=\"1000\" height=\"676\"></span></p>",
    "correct_choice_id": 44623,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11154,
    "choices": [
      {
        "id": 44582,
        "text": "<p><span style=\"font-size:12.0pt;\">Worm infestation</span></p>"
      },
      {
        "id": 44583,
        "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A deficiency</span></p>"
      },
      {
        "id": 44584,
        "text": "<p><span style=\"font-size:12.0pt;\">Scabies</span></p>"
      },
      {
        "id": 44585,
        "text": "<p><span style=\"font-size:12.0pt;\">Filariasis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 33-year-old public health officer is assigned to lead a healthcare team aiming to address and manage endemic conditions in a remote village with limited healthcare access. As part of the initiative, there's a proposal to start a mass drug administration (MDA) program targeting common health concerns in the area. Which of the following conditions would NOT traditionally be managed through mass drug administration? (AIIMS NOV 2019)&nbsp;</span></p>",
    "unique_key": "Q1044570",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305867,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Vitamin A deficiency&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Mass Drug Administration (MDA) refers to providing a drug to an entire population without considering age and gender.</span></li><li><span style=\"font-size:12.0pt;\">Vitamin A prophylaxis is exclusively administered as per the National Immunization Schedule (NIS) to children up to the age of 5.</span></li><li><span style=\"font-size:12.0pt;\">This prophylactic treatment is not intended as a curative measure but rather as a preventive measure.</span></li><li><span style=\"font-size:12.0pt;\">Treatment with vitamin A is reserved solely for children displaying symptoms of vitamin A deficiency, and such treatment is not widespread throughout the community.</span></li><li><span style=\"font-size:12.0pt;\">As a result, it is not categorized as part of Mass Drug Administration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Worm infestation:&nbsp;</strong>Managed through MDA using albendazole or mebendazole to treat and prevent worm infestations in the population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Scabies:&nbsp;</strong>Managed through MDA using ivermectin to treat and prevent scabies outbreaks in the community.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Filariasis:&nbsp;</strong>Managed through MDA using DEC (diethylcarbamazine) and albendazole to prevent and control filariasis in endemic areas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Vitamin A deficiency is managed through targeted prophylaxis in children rather than mass drug administration.</span></li><li><span style=\"font-size:12.0pt;\">In contrast, MDA is carried out for conditions like scabies (using ivermectin), worm infestations (using albendazole), and filariasis (using DEC + albendazole).</span></li></ul>",
    "correct_choice_id": 44583,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11133,
    "choices": [
      {
        "id": 44498,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Call the infection control team of the hospital</span></p>"
      },
      {
        "id": 44499,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mop it</span></p>"
      },
      {
        "id": 44500,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Cover it with 1% sodium hypochlorite</span></p>"
      },
      {
        "id": 44501,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Clean with absorbable material</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">You're an intern in a bustling hospital laboratory. As you're overseeing the day's activities, you notice that a newly appointed technician accidentally spills a blood sample on the floor. The technician, looking panicked, turns to you for guidance. Given the potential risks associated with blood spills, what is the most immediate and appropriate action you should instruct the technician to take? </span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2018)</span></p>",
    "unique_key": "Q5121548",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305846,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) Clean with absorbable material</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">In this situation, the next crucial action to take is to utilize absorbent material for cleaning up the spilled blood. Once the cleaning is complete, the used absorbent material should be disposed of in the designated yellow bin. Subsequently, a sodium hypochlorite solution is employed to thoroughly decontaminate the affected surface. The specific concentrations of sodium hypochlorite employed are as follows:</span></li><li><p style=\"margin-left:40px;\"><span style=\"color:black;font-size:12.0pt;\">&lt; 10 mL blood spill - 1:100 dilution to decontaminate non-porous surfaces</span></p></li><li><p style=\"margin-left:40px;\"><span style=\"color:black;font-size:12.0pt;\">&gt;10 mL blood spill or culture spill - 1:10 dilution for the first application, followed by 1:100 dilution</span></p></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Call the infection control team of the hospital:</strong> While important, this is not the immediate action to take to contain the spill.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Mop it:</strong> Mopping without proper absorbent material and decontamination procedures could spread the contamination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cover it with 1% sodium hypochlorite:</strong> This step should follow the initial clean-up with absorbent material to ensure thorough decontamination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Hypochlorites in Hospital waste Management</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Disinfection of countertops and floors</span></li><li><span style=\"color:black;font-size:12.0pt;\">Decontamination of blood spills</span></li><li><span style=\"color:black;font-size:12.0pt;\">Irrigating agent in endodontic treatment</span></li><li><span style=\"color:black;font-size:12.0pt;\">Disinfectant for manikins, laundry, dental appliances, hydrotherapy tanks</span></li><li><span style=\"color:black;font-size:12.0pt;\">Treatment of liquid medical waste before disposal</span></li><li><span style=\"color:black;font-size:12.0pt;\">Decontaminating water distribution systems in dialysis</span></li></ul>",
    "correct_choice_id": 44501,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 11125,
    "choices": [
      {
        "id": 44466,
        "text": "<p><span style=\"font-size:12.0pt;\">Both sensitivity and specificity increase</span></p>"
      },
      {
        "id": 44467,
        "text": "<p><span style=\"font-size:12.0pt;\">Both sensitivity and specificity decrease</span></p>"
      },
      {
        "id": 44468,
        "text": "<p><span style=\"font-size:12.0pt;\">Sensitivity increases while specificity decreases</span></p>"
      },
      {
        "id": 44469,
        "text": "<p><span style=\"font-size:12.0pt;\">Sensitivity decreases while specificity increases</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A new diagnostic test for dengue is being evaluated using a Receiver Operating Characteristic (ROC) graph. As the curve transitions from the green region to the pink region, what is the most likely change in the test characteristics? (AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip30.jpg\" alt=\"\" width=\"532\" height=\"383\"></p>",
    "unique_key": "Q1256811",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305835,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Both sensitivity and specificity increase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As the curve transitions from green to pink, both sensitivity and specificity experience an increase.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Sensitivity</strong>: Ability of a screening test to identify correctly all those who have the disease (cases)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i>Sensitivity = a/ (a + c) \u00d7 100 = TP/ (TP + FN) \u00d7 100</i></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Specificity</strong>: Ability of a screening test to identify correctly all those who do not have the disease (healthy)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><i>Specificity = d/ (b + d) \u00d7 100 = TN/ (TN + FP) \u00d7 100</i></span></p><p>&nbsp;</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-100044.png\" alt=\"\" width=\"400\" height=\"218\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As the curve transitions from green to pink, it increases the count of true positives and negatives while decreases the occurrences of false positives and negatives. Consequently, this shift results in increased sensitivity and specificity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-100216.png\" alt=\"\" width=\"700\" height=\"197\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">On an ROC graph, a transition from one region to another indicating improved test performance generally means that both sensitivity and specificity are increasing.</span></li></ul>",
    "correct_choice_id": 44466,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 11160,
    "choices": [
      {
        "id": 44606,
        "text": "<p><span style=\"font-size:12.0pt;\">No episode of fever for more than 24 hours with paracetamol</span></p>"
      },
      {
        "id": 44607,
        "text": "<p><span style=\"font-size:12.0pt;\">After the return of appetite</span></p>"
      },
      {
        "id": 44608,
        "text": "<p><span style=\"font-size:12.0pt;\">Urine output more than 200ml</span></p>"
      },
      {
        "id": 44609,
        "text": "<p><span style=\"font-size:12.0pt;\">After 24hrs from recovery of shock</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old woman is admitted with dengue hemorrhagic fever. After several days of management, her condition stabilizes, and the medical team considers discharging her. Which of the following is an appropriate criterion to decide the discharge of a patient recovering from dengue hemorrhagic shock? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q3607054",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305873,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) After the return of appetite</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The appropriate criteria for discharging a patient recovering from dengue hemorrhagic shock include several clinical signs indicating recovery and stability.</span></li><li><span style=\"font-size:12.0pt;\">One crucial criterion is the return of appetite, which signifies a significant clinical improvement and recovery from the acute phase of the illness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>SIGNS OF RECOVERY:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Stable pulse, blood pressure and breathing rate</span></li><li><span style=\"font-size:12.0pt;\">Normal temperature</span></li><li><span style=\"font-size:12.0pt;\">No evidence of external or internal bleeding</span></li><li><span style=\"font-size:12.0pt;\">Return of appetite</span></li><li><span style=\"font-size:12.0pt;\">No vomiting</span></li><li><span style=\"font-size:12.0pt;\">Good urine output&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Stable haematocrit&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Convalescent confluent petechiae rash</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. No episode of fever for more than 24 hours with paracetamol:&nbsp;</strong>The absence of fever should be without the use of antipyretics like paracetamol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Urine output more than 200 ml:&nbsp;</strong>This is not a standard criterion; adequate urine output should be considered, but specific volume thresholds are not typically used.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. After 24 hours from recovery of shock:&nbsp;</strong>Recovery from shock should be sustained, and other criteria like appetite and clinical stability are more reliable indicators.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>CRITERIA FOR DISCHARGING PATIENTS:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Absence of fever for at least 24 hours without the use of anti-fever therapy</span></li><li><span style=\"font-size:12.0pt;\">Return of appetite</span></li><li><span style=\"font-size:12.0pt;\">Visible clinical improvement&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Good urine output&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Minimum of three days after recovery from shock</span></li><li><span style=\"font-size:12.0pt;\">No respiratory distress from pleural effusion and no ascites</span></li><li><span style=\"font-size:12.0pt;\">Platelet count of more than 50,000/mm</span></li></ul>",
    "correct_choice_id": 44607,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 11165,
    "choices": [
      {
        "id": 44626,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence increases and prevalence reduces</span></p>"
      },
      {
        "id": 44627,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence reduces and prevalence remains the same</span></p>"
      },
      {
        "id": 44628,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence remains the same and prevalence increases</span></p>"
      },
      {
        "id": 44629,
        "text": "<p><span style=\"font-size:12.0pt;\">Incidence reduces and prevalence increases</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A team of oncologists is implementing a new treatment strategy for metastatic melanoma that significantly improves overall survival rates for patients. How would you categorize the change in incidence and prevalence of metastatic melanoma in the population treated at this center? (INICET NOV 2020)</span></p>",
    "unique_key": "Q5482403",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305878,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Incidence remains the same and prevalence increases</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The given scenario shows that there is a new treatment which can extend overall survival but cannot cure a particular disease.</span></li><li><span style=\"font-size:12.0pt;\">So, old cases will live longer and thus, there will be increase in prevalence. Incidence will not get affected due to this.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Incidence increases and prevalence reduces:</strong> Incorrect as the new treatment does not affect the number of new cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Incidence reduces and prevalence remains the same:</strong> Incorrect because the incidence is unaffected by treatment, and the prevalence would increase due to longer survival.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Incidence reduces and prevalence increases:</strong> Incorrect because the incidence remains the same.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>PREVALENCE</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Total current (Old + New) cases in a given population over.</span></li><li><span style=\"font-size:12.0pt;\">Prevalence = Incidence \u00d7 Mean duration of disease [P = I \u00d7 d]</span></li><li><span style=\"font-size:12.0pt;\">Prevalence describes the balance between incidence, mortality and recovery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>INCIDENCE</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Number of new cases occurring in a defined population over a specified period of time.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note - A treatment that extends the lives of patients with a chronic condition will increase prevalence, even if incidence remains stable.</strong></span></p>",
    "correct_choice_id": 44628,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 11159,
    "choices": [
      {
        "id": 44602,
        "text": "<p><span style=\"font-size:12.0pt;\">IV Fluids</span></p>"
      },
      {
        "id": 44603,
        "text": "<p><span style=\"font-size:12.0pt;\">Platelets</span></p>"
      },
      {
        "id": 44604,
        "text": "<p><span style=\"font-size:12.0pt;\">Cryoglobulins</span></p>"
      },
      {
        "id": 44605,
        "text": "<p><span style=\"font-size:12.0pt;\">FFP</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">During your clinical rotation in infectious diseases, a patient with dengue fever develops warning signs like abdominal pain, persistent vomiting, clinical fluid accumulation, and an increase in hematocrit with a decrease in platelet count. Which of the following is the cornerstone of management for a patient showing warning signs of dengue? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q7913479",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305872,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) IV Fluids&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The mainstay treatment for patients with dengue showing warning signs is intravenous (IV) fluid therapy.</span></li><li><span style=\"font-size:12.0pt;\">This approach is crucial to prevent progression to severe dengue, including dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Platelets:&nbsp;</strong>Only indicated if there is severe thrombocytopenia (&lt;10,000/mm\u00b3) with active bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cryoglobulins:&nbsp;</strong>Not relevant for dengue management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. FFP (Fresh Frozen Plasma):&nbsp;</strong>Not a primary treatment for dengue with warning signs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/21/screenshot-2024-09-21-111607.png\" alt=\"\" width=\"1000\" height=\"683\"></p>",
    "correct_choice_id": 44602,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 57601,
    "choices": [
      {
        "id": 229773,
        "text": "<p><span style=\"font-size:12.0pt;\">Zika virus disease</span></p>"
      },
      {
        "id": 229774,
        "text": "<p><span style=\"font-size:12.0pt;\">Dengue disease</span></p>"
      },
      {
        "id": 229775,
        "text": "<p><span style=\"font-size:12.0pt;\">Yellow fever disease</span></p>"
      },
      {
        "id": 229776,
        "text": "<p><span style=\"font-size:12.0pt;\">Nipah virus disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old male patient presented to OPD with fever and neurological complications. He was having respiratory difficulty during the examination. Identify the disease transmitted through the life cycle shown in the image. (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-18-174506.jpg\" alt=\"\" width=\"400\" height=\"274\"></span></p>",
    "unique_key": "Q7445974",
    "question_audio": null,
    "question_video": null,
    "map_id": 34306011,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Nipah virus disease</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The life cycle shown in the image involves Pteropus bats, also known as fruit bats or flying foxes, which are natural reservoirs for the Nipah virus. The transmission cycle depicted shows bats contaminating fruits or other food sources with their secretions, which can then be consumed by humans or other animals like pigs, leading to the spread of the virus. Nipah virus is known for causing severe respiratory illness and neurological symptoms, with <strong>a high fatality rate of around 50%</strong>. There is <strong>no vaccine</strong> for Nipah virus, and <strong>treatment is primarily supportive and symptomatic</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Incubation period \u2013 4-14 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Zika virus disease:</strong> Zika virus is primarily transmitted through mosquito bites and does not involve bats or fruit contamination in its transmission cycle. It primarily causes mild symptoms and is not associated with the severe respiratory and neurological symptoms described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Dengue disease:</strong> Dengue is transmitted by Aedes mosquitoes and does not involve bats or fruit contamination. It typically presents with fever, headache, and joint pain rather than severe neurological symptoms or respiratory difficulty.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Yellow fever disease:</strong> Yellow fever is also transmitted through mosquito bites, mainly the Aedes and Haemagogus species, and does not involve bats. It causes fever, jaundice, and bleeding but does not match the transmission cycle or clinical presentation described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Nipah virus is transmitted through contact with Pteropus bats, contaminated food, or animals that have been exposed to the virus. It causes severe respiratory and neurological symptoms with a high fatality rate and no available vaccine.</span></p>",
    "correct_choice_id": 229776,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11135,
    "choices": [
      {
        "id": 44506,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Cytotoxic waste</span></p>"
      },
      {
        "id": 44507,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Biomedical waste</span></p>"
      },
      {
        "id": 44508,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Radiation hazard</span></p>"
      },
      {
        "id": 44509,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Biohazard</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">Based on the emblem as shown below, which of the following best describes the warning it signifies? </span><span style=\"font-size:12.0pt;\">(AIIMS NOV 2018)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip37.jpg\" alt=\"\" width=\"300\" height=\"302\"></p>",
    "unique_key": "Q7675897",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305848,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) Radiation hazard</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>INTERNATIONAL RADIATION SYMBOL (TREFOIL)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Central circle of radius R, an internal radius of 1.5R and an external radius of 5R for the blades, which are separated from each other by 60\u00b0</span></li><li><span style=\"color:black;font-size:12.0pt;\">Trefoil is black in the international version</span></li><li><span style=\"color:black;font-size:12.0pt;\">Commonly referred to as a Radioactivity warning sign, but it is actually a warning sign of ionizing radiation</span></li><li><span style=\"color:black;font-size:12.0pt;\">Includes X-ray apparatus, medical beam cannons and particle accelerators.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cytotoxic waste:</strong> This waste includes materials that are toxic to cells, such as chemotherapy waste, but uses a different symbol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Biomedical waste:</strong> This refers to waste generated from medical procedures, often marked with a biohazard symbol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Biohazard:</strong> Indicates the presence of biological substances that pose a threat to human health, marked with a different symbol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip38.jpg\" alt=\"\" width=\"700\" height=\"243\"></span></p>",
    "correct_choice_id": 44508,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 11084,
    "choices": [
      {
        "id": 44302,
        "text": "<p><span style=\"font-size:12.0pt;\">60 mg elemental iron + 500 mcg folic acid daily</span></p>"
      },
      {
        "id": 44303,
        "text": "<p><span style=\"font-size:12.0pt;\">60 mg elemental iron + 500 mcg folic acid weekly</span></p>"
      },
      {
        "id": 44304,
        "text": "<p><span style=\"font-size:12.0pt;\">100 mg elemental iron + 500 mcg folic acid weekly</span></p>"
      },
      {
        "id": 44305,
        "text": "<p><span style=\"font-size:12.0pt;\">100 mg elemental iron + 500 mcg folic acid daily</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Dr. Sanjana is leading a health initiative in Karnataka, focusing on the prevention of anemia among adult women through the Anemia Mukth Bharath initiative. She needs to communicate the correct dosage of iron and folic acid supplementation. What is the recommended dose according to the guidelines? (AIIMS MAY 2020)</span></p>",
    "unique_key": "Q6541386",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305823,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 60 mg elemental iron + 500 mcg folic acid weekly</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">As per the Anemia Mukth Bharat initiative guidelines, it is recommended for adult females to consume 60 mg of elemental iron along with 500 mcg of folic acid in tablet form on a weekly basis.</span></li><li><span style=\"font-size:12.0pt;\">These tablets have a sugar-coated exterior and are colored red.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-192707.jpg\" alt=\"\" width=\"800\" height=\"379\"></span></p>",
    "correct_choice_id": 44303,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 11147,
    "choices": [
      {
        "id": 44554,
        "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
      },
      {
        "id": 44555,
        "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
      },
      {
        "id": 44556,
        "text": "<p><span style=\"font-size:12.0pt;\">5</span></p>"
      },
      {
        "id": 44557,
        "text": "<p><span style=\"font-size:12.0pt;\">6</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A study on 100 urban women evaluates potential risk factors for breast cancer using odds ratios (OR) and 95% confidence intervals (CI). An OR &gt; 1 with a CI not including 1 suggests a significant association. How many risk factors show a statistically significant association with breast cancer? (AIIMS NOV 2019)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip40.jpg\" alt=\"\" width=\"636\" height=\"329\"></p>",
    "unique_key": "Q3451122",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305860,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\"><strong>Ans. A. 3</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">In the above statistical group, the odds ratio of early menarche, BRCA mutation, and obesity show positive association and are statistically significant.</span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">A high socioeconomic status does not pose a risk factor. Despite observing a positive correlation, the statistical significance is absent. Any correlation with a 95% confidence interval with the value of 1.0 is deemed as statistically insignificant. A value of 1.0 within this range implies that both factors can coexist without one being the cause of the other.</span></p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">Odds ratio (OR) is the key parameter in case-control studies to assess the strength of association between the exposure and outcome. The interpretation of the odds ratio can be done as below:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">OR &gt; 1 indicates a positive association.</span></li><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">OR = 1 indicates no association.</span></li><li><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">OR &lt; 1 indicates a negative (protective) association.</span></li></ul><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">Interpretation of the individual factors given in the question:</span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_IjtklbT.png\" width=\"914\" height=\"737\"></span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:hsl(0, 0%, 100%);font-size:12.0pt;\">There are three factors (early menarche, BRCA mutation, obesity), that have statistically significant associations with breast cancer according to the odds ratios and their 95% confidence intervals provided.</span></p>",
    "correct_choice_id": 44554,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 57821,
    "choices": [
      {
        "id": 230645,
        "text": "<p><span style=\"font-size:12.0pt;\">Normal distribution, evident outliers, negative skewness, positive skewness&nbsp;</span></p>"
      },
      {
        "id": 230646,
        "text": "<p><span style=\"font-size:12.0pt;\">Evident positive skewness, normal distribution, negative skewness, outliers present&nbsp;</span></p>"
      },
      {
        "id": 230647,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Binominal&nbsp;</span><span style=\"font-size:12.0pt;\">distribution, outliers present, skewed negatively, skewed positively&nbsp;</span></p>"
      },
      {
        "id": 230648,
        "text": "<p><span style=\"font-size:12.0pt;\">Standard distribution, outliers present, evident positive skewness, negative skewness</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A hospital biostatistician analyzes patient wait times over several months to find patterns and outliers for optimizing patient flow. After analyzing four different months, the following box plots are created to illustrate the findings. Based on the given plots, match the correct description?&nbsp;(AIIMS NOV 2017)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-185312.png\" alt=\"\" width=\"300\" height=\"189\"></span></p>",
    "unique_key": "Q8020765",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305843,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:16px;\"><strong>Ans. A) Normal distribution, evident outliers, negative skewness, positive skewness</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Plot 1 \u2013 Normal distribution</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">The box is roughly centered with whiskers of nearly equal length on both sides and no extreme values. This symmetry and lack of outliers indicate an&nbsp;<strong>approximately normal</strong> spread of wait times.</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Plot 2 \u2013 Evident outliers</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Two data points lie clearly beyond the upper whisker (marked in red). These are&nbsp;<strong>outliers</strong>, while the central box and whiskers remain fairly symmetric.</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Plot 3 \u2013 Negative skewness</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">The <strong>lower whisker</strong> (toward shorter wait times) is substantially longer than the upper whisker, and the median line sits above the box\u2019s center. This shows a&nbsp;<strong>left (negative) skew</strong>, where a few very short waits pull the lower tail.</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Plot 4 \u2013 Positive skewness</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">The&nbsp;<strong>upper whisker</strong> (toward longer wait times) is longer than the lower whisker, and the median is below the box\u2019s center. This pattern reflects a&nbsp;<strong>right (positive) skew</strong>, due to some unusually long waits.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Box and whisker plot&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Description: A convenient way of graphically depicting groups of numerical data through their quartiles&nbsp;</span></li><li><span style=\"font-size:16px;\">Edges of box: 1st and 3rd Quartile&nbsp;</span></li><li><span style=\"font-size:16px;\">Line in Box: 2nd Quartile (Median)&nbsp;</span></li><li><span style=\"font-size:16px;\">Whiskers end: Minimum &amp; maximum values&nbsp;</span></li><li><span style=\"font-size:16px;\">Outlier: A data point that is located outside the whiskers of the box plot</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-185424.png\" alt=\"\" width=\"500\" height=\"250\"></span></p>",
    "correct_choice_id": 230645,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased"
    ]
  }
];
        let quizName = 'Late Night Pyq (Inicet, Psm-2)';
        let hierarchy = ["Cerebellum", "Late Night PYQ INICET"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - QuizMaster Pro';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>